syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.07941569	100.0
SMITH-MAGENIS SYNDROME; SMS	5.150549014	63.749028538968524
PANDAS	2.7727338099999996	34.3184942622998
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.21471485	27.41181955449058
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	25.010096738815037
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.99228753013945
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	24.754265366930266
NARCOLEPSY 1; NRCLP1	1.8373013	22.74052196960298
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.42459584	17.632411731992466
CRI-DU-CHAT SYNDROME	1.4107298399999997	17.460790410203536
MONOSOMY 22Q13.3	1.389194554	17.19424531800517
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	1.3736082	17.001330946495713
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	1.3736082	17.001330946495713
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	1.3736082	17.001330946495713
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	1.3736082	17.001330946495713
DIGEORGE SYNDROME; DGS	1.3002878539999998	16.093835295656138
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	1.2636986	15.64096524410913
BRAIN-LUNG-THYROID SYNDROME	1.244083034	15.398180781065864
16P12.1P12.3 TRIPLICATION SYNDROME	1.21163592	14.996578545892348
CITRULLINEMIA TYPE II	1.1880606040000001	14.704783731705728
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.13809296	14.086327572037577
TRICHOTHIODYSTROPHY	1.1349858839999998	14.047870880127963
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.11146498	13.756749530484921
SCHIZOPHRENIA	1.0894928	13.484796943279942
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.202275274933898
IMMUNODEFICIENCY 61; IMD61	1.0562001399999998	13.072729273074449
IMMUNODEFICIENCY 13; IMD13	1.03703706	12.835545289290595
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	1.0175439	12.594275861550578
DISTAL 16P11.2 MICRODELETION SYNDROME	1.012721444	12.534587683778406
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	12.52447997263525
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	1.0111107000000001	12.514651291571314
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.00671141	12.46020069552827
PROLIDASE DEFICIENCY	1.00359712	12.42165471498348
CHAR SYNDROME	1.0017908839999998	12.399298692353828
BROWN SYNDROME	1.0	12.377132683465133
TARDIVE DYSKINESIA	1.0	12.377132683465133
STRABISMUS, SUSCEPTIBILITY TO	1.0	12.377132683465133
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	1.0	12.377132683465133
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	1.0	12.377132683465133
SECRETORY COMPONENT DEFICIENCY	1.0	12.377132683465133
KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE	1.0	12.377132683465133
LEISHMANIASIS, TEGUMENTARY	1.0	12.377132683465133
CORONAVIRUS 229E SUSCEPTIBILITY	1.0	12.377132683465133
PLUMMER-VINSON SYNDROME	1.0	12.377132683465133
POLYEMBRYOMA	1.0	12.377132683465133
CARTILAGE-HAIR HYPOPLASIA; CHH	1.0	12.377132683465133
AASE-SMITH SYNDROME I	1.0	12.377132683465133
KIFAFA SEIZURE DISORDER	1.0	12.377132683465133
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.980114454	12.131006642139983
DUPLICATION/INVERSION 15Q11	0.94523558	11.699306190792122
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.9085285000000001	11.244977791209553
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.84883472	10.506139955771976
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137846
7Q11.23 MICRODUPLICATION SYNDROME	0.8368654199999999	10.357994341543774
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328385
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	9.433789883386977
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.74627125	9.236698279105381
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.7262161199999999	8.988473274111236
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609603
POSTENCEPHALITIC PARKINSONISM	0.7008730400000001	8.674798610343567
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.7005455540000001	8.67074527266959
ACUTE ADRENAL INSUFFICIENCY	0.666667	8.251425914687651
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505000000001	8.221516573558057
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.1869378353523
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.65936251	8.161017272772607
48,XXXY SYNDROME	0.6482769640000001	8.023809999061951
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.6448411	7.9812838544516085
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.6317458	7.819201588821828
INHERITED CREUTZFELDT-JAKOB DISEASE	0.6182391599999999	7.652028113434028
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.594678234	7.360411406186726
XQ12-Q13.3 DUPLICATION SYNDROME	0.5919494699999999	7.326637132096862
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.5823325100000001	7.2076067421652885
IMMUNODEFICIENCY 21; IMD21	0.5804094	7.183804154530388
MUCOPOLYSACCHARIDOSIS TYPE 2	0.567459044	7.0235158800202795
BARE LYMPHOCYTE SYNDROME, TYPE II	0.5671252000000001	7.019383848536702
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5641516299999999	6.9825795781031275
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.9167446191891635
MANGANESE POISONING	0.53548949	6.6278244683310765
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.535012584	6.621921739491535
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.52677921	6.520016177060945
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.52677921	6.520016177060945
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.52677921	6.520016177060945
MANNOSE-BINDING LECTIN DEFICIENCY	0.525	6.497994658819195
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.5140845	6.362892067012832
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.513052284	6.350116192622836
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	6.339506712520693
MOMO SYNDROME	0.5082875800000001	6.2911428190173995
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.503557604	6.232599278475794
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.50190476	6.212141808982723
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.500545554	6.195318735976562
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.5	6.1885663417325665
SEMANTIC DEMENTIA	0.5	6.1885663417325665
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.1885663417325665
ZUNICH NEUROECTODERMAL SYNDROME	0.5	6.1885663417325665
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.1885663417325665
VIRAL HEMORRHAGIC FEVER	0.5	6.1885663417325665
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.5	6.1885663417325665
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	6.1885663417325665
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.1885663417325665
BARTH SYNDROME; BTHS	0.5	6.1885663417325665
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.016818154333634
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.48350111	5.984357391072671
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.47802971000000005	5.91663714730836
IDIOPATHIC BRONCHIECTASIS	0.47549050000000004	5.885209008227179
16P13.2 MICRODELETION SYNDROME	0.461820364	5.7160119211541645
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.4591872	5.683420900948842
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.458333	5.672848354210625
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.458333	5.672848354210625
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.45177921000000004	5.591731225801059
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.45177921000000004	5.591731225801059
AUTISM	0.45177921000000004	5.591731225801059
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445000000004	5.568155758550901
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44473696	5.504568363160926
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574126
WILLIAMS SYNDROME	0.42132148	5.2147518603539025
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.06479745195534
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.4047616	5.0097880283716405
CHILDHOOD DISINTEGRATIVE DISORDER	0.40057911	4.9580207946943755
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.4	4.950853073386054
PALLISTER-HALL SYNDROME	0.39641460399999995	4.906476151371288
X-LINKED ADRENOLEUKODYSTROPHY	0.39616841999999997	4.903429099338742
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.39560000999999995	4.896393813350134
11Q22.2Q22.3 MICRODELETION SYNDROME	0.395377834	4.893643911519052
IMMUNODEFICIENCY DUE TO INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE-4 DEFICIENCY	0.392857	4.862443214628062
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.39047610000000005	4.832974499422001
LEUKOCYTE ADHESION DEFICIENCY	0.38353785	4.747098858580948
CHROMOSOME 17Q12 DELETION SYNDROME	0.38266461	4.736290651236439
CHILDHOOD APRAXIA OF SPEECH	0.37655271	4.660642853988368
IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACEGLYCOPROTEIN	0.3748094	4.639065674809957
49,XXXXY SYNDROME	0.37101014400000004	4.592041779199507
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.37023809999999996	4.582486088174032
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.366616654	4.5376629705260285
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.36376551399999996	4.502374032446893
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36324359000000006	4.49591410984821
ATYPICAL TERATOID RHABDOID TUMOR	0.36277170999999997	4.490073588477535
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.438032572625311
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.358103654	4.43229643999169
ESOPHAGEAL ATRESIA	0.35359712	4.376518470731143
ANGELMAN SYNDROME	0.35319678400000004	4.371563458941176
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.34956927	4.326665236852048
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829093
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.3494019	4.324593676154817
ADNP SYNDROME	0.34824542999999997	4.310279893520369
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.34554629	4.276872279609121
NON-DISTAL MONOSOMY 20Q	0.34535919	4.274556518084045
PAPILLON-LEFÈVRE SYNDROME	0.34450622	4.2639991952190295
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896494
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.342057784	4.233694577980057
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.3409091	4.2194771637006845
ACNE INVERSA, FAMILIAL, 3; ACNINV3	0.3409091	4.2194771637006845
PLACENTAL INSUFFICIENCY	0.34037525	4.212869631417616
SPINOCEREBELLAR ATAXIA TYPE 42	0.33902277	4.196129807005883
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361182
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361182
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361182
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.3368295	4.16898341320522
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.335783314	4.156034630271636
PRADER-WILLI SYNDROME	0.33571779999999996	4.1552237548010105
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.33553349000000005	4.1529425254761225
POTOCKI-LUPSKI SYNDROME	0.334853904	4.144531199384296
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.333878554	4.132459163021478
ELSAHY-WATERS SYNDROME; ESWS	0.333878554	4.132459163021478
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.333878554	4.132459163021478
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.33370320000000003	4.130288783296903
MAST SYNDROME	0.333333	4.1257067687774835
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	4.1257067687774835
PITUITARY CARCINOMA	0.333333	4.1257067687774835
ANAPLASTIC THYROID CARCINOMA	0.333333	4.1257067687774835
VARICELLA, SEVERE RECURRENT	0.333333	4.1257067687774835
ISOLATED CLEFT LIP	0.333333	4.1257067687774835
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.06953810294665
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.3196921	3.956871539555604
ADULT IDIOPATHIC NEUTROPENIA	0.3163302	3.9152608571870626
CHROMOSOME 1P36 DELETION SYNDROME	0.314267084	3.8897253967136822
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.8560376387812774
GITELMAN SYNDROME	0.31040850000000003	3.841967190575388
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.30352690399999993	3.7567927638093837
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.297372674	3.6806210425348227
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.294281164	3.6423570130725627
LEPTIN DEFICIENCY OR DYSFUNCTION	0.2940294	3.639240896639643
MYOCLONUS-DYSTONIA SYNDROME	0.29335654999999994	3.630912942913573
2Q23.1 MICRODELETION SYNDROME	0.29246644	3.619895933340694
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882257
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882257
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.28951177399999994	3.5833256402233706
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.28927411000000003	3.580384041361289
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2878137	3.5623083530190294
CHRISTIANSON SYNDROME	0.28332509	3.506752231484701
HYPERTRYPTOPHANEMIA; HYPTRP	0.278518564	3.4472612214361757
ALLAN-HERNDON-DUDLEY SYNDROME	0.27840452	3.4458496837164225
21Q22.11Q22.12 MICRODELETION SYNDROME	0.27777280000000004	3.4380308014576246
WILLIAMS-BEUREN SYNDROME; WBS	0.27687041	3.426861800695392
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.2764808	3.4220395460305872
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.2758749	3.4145402413376753
1P21.3 MICRODELETION SYNDROME	0.27544496399999996	3.4092188664202765
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.275405	3.4087242266897153
SYDENHAM CHOREA	0.27415040999999996	3.393195999796366
MARFAN SYNDROME; MFS	0.27066968	3.3501145427510495
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27066968	3.3501145427510495
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.26805249999999997	3.3177213586345373
PRADER-WILLI-LIKE SYNDROME	0.267990744	3.3169569964285377
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.26731353	3.308575028895438
LYSINURIC PROTEIN INTOLERANCE	0.2636986	3.263832560643999
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.263143404	3.2569608260866705
WILSON DISEASE	0.25918378	3.207952034462037
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25847458	3.1991741719629236
CHOANAL ATRESIA	0.25756512	3.1879176648726193
PREECLAMPSIA	0.25724638	3.1839725776010916
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.250545554	3.1010355651102786
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.25	3.0942831708662832
GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS	0.25	3.0942831708662832
HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	0.25	3.0942831708662832
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	3.0942831708662832
MÉNÉTRIER DISEASE	0.25	3.0942831708662832
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	3.0942831708662832
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.24995319000000002	3.0937037972853707
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.2460001	3.0447758778456913
CONGENITAL MYASTHENIC SYNDROME	0.2460001	3.0447758778456913
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.24304638399999998	3.008217343004417
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.0037189483934084
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.239857604	2.9687493898460375
ADENYLOSUCCINASE DEFICIENCY	0.239634944	2.965993497482737
SPASTIC PARAPLEGIA 16, X-LINKED	0.23927943	2.961593253533908
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362	2.951124550938906
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.23790247400000003	2.9445504864226146
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.23225810000000002	2.8746893205095136
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.22945839999999998	2.840037062135616
PHELAN-MCDERMID SYNDROME	0.22804404399999997	2.822531390261961
PITT-HOPKINS-LIKE SYNDROME	0.22800763000000004	2.822080689352426
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.22798128399999995	2.821754601414746
NARCOLEPSY 7; NRCLP7	0.2261903	2.799587354812784
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.7910378504116804
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.22545869400000002	2.7905321702787647
TUBEROUS SCLEROSIS COMPLEX	0.22452100000000003	2.7789262072242757
POPOV-CHANG SYNDROME; POPCHAS	0.223889314	2.771107745787988
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.7535408318618155
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.22222199999999998	2.7504711791849887
POLYARTERITIS NODOSA	0.2208333	2.733283055027461
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.220487524	2.7290033395967033
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417225
PARAGANGLIOMAS 4	0.216667	2.68171620712834
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.216667	2.68171620712834
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004000000003	2.657618424878941
SCHIZOPHRENIA 10	0.21449279999999998	2.65480584524795
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.21211576400000004	2.625384955282578
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.21037934000000003	2.6038930050398243
PAROXYSMAL HEMICRANIA	0.20990245	2.5979904742344058
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.591407077360071
CLEFT VELUM	0.20925926	2.5900296262637283
NARCOLEPSY TYPE 1	0.20893710000000001	2.5860422091984234
VELOCARDIOFACIAL SYNDROME	0.20890709999999998	2.585670895217919
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.20877193000000002	2.5839978781930952
RHABDOID TUMOR	0.20671141	2.558494548756162
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184	2.5556531304060184
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.5460857306130267
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.5460857306130267
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.20470840400000004	2.533703077728385
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.20444444	2.5304359602767263
APNEA, OBSTRUCTIVE SLEEP	0.2036865	2.521054836330621
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.20339339	2.5174269749697706
MUCOLIPIDOSIS TYPE II	0.20148103000000003	2.4937574415112196
TRANSALDOLASE DEFICIENCY	0.20054555400000001	2.482178930937022
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	2.475426536693027
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.2	2.475426536693027
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.2	2.475426536693027
BENIGN SCHWANNOMA	0.2	2.475426536693027
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	2.475426536693027
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	2.475426536693027
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	2.475426536693027
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.475426536693027
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	2.475426536693027
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	2.475426536693027
EPISODIC ATAXIA, TYPE 4	0.2	2.475426536693027
MALARIA	0.2	2.475426536693027
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	2.475426536693027
RADIATION PROCTITIS	0.2	2.475426536693027
PULMONARY ARTERIOVENOUS MALFORMATION	0.2	2.475426536693027
FAMILIAL ADENOMATOUS POLYPOSIS	0.2	2.475426536693027
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.2	2.475426536693027
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.475426536693027
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	2.475426536693027
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.475426536693027
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.199729394	2.472077210326085
8Q24.3 MICRODELETION SYNDROME	0.19910860400000002	2.4643936101275172
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.198029534	2.45103781756277
PEDIATRIC-ONSET GRAVES DISEASE	0.19800696399999998	2.4507584656781036
PROGRESSIVE NON-FLUENT APHASIA	0.19787205000000002	2.4490886171992474
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.19763954	2.4462108100790148
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.1970761	2.439237038439843
HEREDITARY COPROPORPHYRIA	0.19663756000000002	2.4338091706728364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.19449443	2.4072833663049216
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.378470886673737
MONOSOMY X	0.19200631999999998	2.376487698703865
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.19200631999999998	2.376487698703865
MOSAIC MONOSOMY X	0.19200631999999998	2.376487698703865
TURNER SYNDROME	0.19200631999999998	2.376487698703865
DRACUNCULIASIS	0.1909091	2.3629072611809137
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.189646084	2.3472747445675743
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.189525514	2.3457824336799287
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.189306384	2.343070232595001
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.18826225400000002	2.330146897046215
TRIGEMINAL NEURALGIA	0.18777814	2.324154953834292
GITELMAN SYNDROME	0.1870752	2.315454572185777
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.3113591027521454
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18629060000000003	2.3057434738823304
DDOST-CDG	0.18539768	2.2946916845666103
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.1852756	2.293180684208613
CUSHING DISEASE	0.18523063	2.2926240845518375
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263573
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263573
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.275064275099825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.183707704	2.2737746273827386
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.18333370000000002	2.269145530250592
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18292109999999998	2.2640387253053937
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.263245351100384
SOTOS SYNDROME	0.18199121399999998	2.2525294029028973
WITTEVEEN-KOLK SYNDROME	0.18076855399999997	2.2373963778561317
XIA-GIBBS SYNDROME	0.180448534	2.2334354478547693
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.17894343000000001	2.2148065759443556
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.17838314999999996	2.207871916044463
PITT-HOPKINS SYNDROME	0.17769443399999998	2.199347586731238
BARDET-BIEDL SYNDROME 16; BBS16	0.176471814	2.18421505676978
PLAGUE	0.17603755000000001	2.178840113622128
2Q32Q33 MICRODELETION SYNDROME	0.175971204	2.1780189403771106
INSULINOMA	0.17526791	2.1693141772236255
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.17479859999999997	2.1635054650839485
KOOLEN-DE VRIES SYNDROME; KDVS	0.174206054	2.156171444620892
IMMUNODEFICIENCY 46; IMD46	0.173611	2.1488063823090653
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090653
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286090999999998	2.1395224188545248
CHROMOSOME 16P13.2 DELETION SYNDROME	0.17205199400000004	2.1295103581927477
AURICULOCONDYLAR SYNDROME	0.17197395399999998	2.1285444467581294
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.17195189400000002	2.1282714072111326
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.170542214	2.110823610809905
TRISOMY 8P	0.16983503	2.1020707006102817
KOOLEN-DE VRIES SYNDROME	0.168457884	2.0850255818437784
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.168457884	2.0850255818437784
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.16836796399999998	2.0839126300728807
MCLEOD SYNDROME; MCLDS	0.16835655	2.083771357480432
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.077588360848407
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.167212554	2.0696119671990787
CEREBROOCULONASAL SYNDROME	0.166667	2.062859572955084
ONDINE SYNDROME	0.166667	2.062859572955084
MELIOIDOSIS	0.166667	2.062859572955084
PARAGANGLIOMAS 3	0.166667	2.062859572955084
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.062859572955084
DERMATOLEUKODYSTROPHY	0.166667	2.062859572955084
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.166667	2.062859572955084
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.166667	2.062859572955084
PARAGANGLIOMAS 1	0.166667	2.062859572955084
AL AMYLOIDOSIS	0.166667	2.062859572955084
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.062859572955084
ADDISON DISEASE	0.166667	2.062859572955084
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	2.062859572955084
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.062859572955084
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.166667	2.062859572955084
MICROSPORIDIOSIS	0.166667	2.062859572955084
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.16621242000000003	2.0572331759798343
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.16620086	2.057090096326013
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.165421544	2.0474443987916655
PERRY SYNDROME	0.16532722000000002	2.0462769381284307
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515104
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.1641336	2.031503345014793
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.1637426	2.026663886135558
PGM3-CDG	0.161764	2.002174491408054
MELAS	0.16137008	1.9972988913013836
49,XYYYY SYNDROME	0.16107896	1.9936956604345728
MYOTONIC DYSTROPHY 1	0.16025640000000002	1.9835147261744623
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.981559139210474
SPINOCEREBELLAR ATAXIA TYPE 7	0.15999620399999998	1.980294245758755
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.159638054	1.9758613756881718
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.15963097399999998	1.9757737455887727
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.1589598	1.967466535937081
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.9449760481379565
VICI SYNDROME; VICIS	0.156178974	1.9330478835654512
CHRONIC HICCUP	0.15454781999999997	1.912858874080286
LENNOX-GASTAUT SYNDROME	0.15430775	1.909887495836967
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.1536037	1.9011733755711735
DRAVET SYNDROME	0.15188942	1.8799555045545628
L-2-HYDROXYGLUTARIC ACIDURIA	0.15162893	1.876731385261847
DIENCEPHALIC SYNDROME	0.15162893	1.876731385261847
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.150948274	1.8683068156380502
BECKWITH-WIEDEMANN SYNDROME	0.15076845	1.8660811101303787
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.14925531	1.8473527755817205
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454781
COFFIN-SIRIS SYNDROME 1; CSS1	0.14709080399999996	1.8205623976255636
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1468253	1.817276219389573
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14645412	1.8126820752801247
17Q24.2 MICRODELETION SYNDROME	0.14643327	1.8124240120636748
3Q27.3 MICRODELETION SYNDROME	0.14511246	1.796076171444027
49,XXXYY SYNDROME	0.14506307	1.7954648648607903
EMANUEL SYNDROME	0.144564074	1.789288725160272
NIJMEGEN BREAKAGE SYNDROME	0.144376	1.786960908307962
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001189
8Q22.1 MICRODELETION SYNDROME	0.143402554	1.7749124380057737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.143402554	1.7749124380057737
PRIMARY BILIARY CHOLANGITIS	0.14336909999999997	1.774498373408981
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617784
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617784
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.14285699999999998	1.7681600437617784
INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	0.14285699999999998	1.7681600437617784
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.14285699999999998	1.7681600437617784
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617784
LI-FRAUMENI SYNDROME	0.14285699999999998	1.7681600437617784
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617784
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.14285699999999998	1.7681600437617784
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617784
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.14285699999999998	1.7681600437617784
NEUROBLASTOMA	0.14285699999999998	1.7681600437617784
PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	0.14285699999999998	1.7681600437617784
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617784
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617784
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617784
PERINEURAL CYST	0.14285699999999998	1.7681600437617784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.140651204	1.7408586139971218
HUNTINGTON DISEASE-LIKE 1	0.14042569	1.7380673972971428
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.140179534	1.735020691824312
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.13968239999999998	1.72886759834485
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525000000003	1.719496252333565
IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTSAND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES	0.1386986	1.7166909752108575
LUSCAN-LUMISH SYNDROME; LLS	0.13822633400000003	1.7108456762669682
CYSTIC FIBROSIS	0.13710029999999998	1.696908604042875
ADRENOCORTICAL CARCINOMA	0.13663752	1.691180714579621
48,XYYY SYNDROME	0.136601954	1.690740509478601
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13483588	1.6688815772517827
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13402696	1.658869467081474
GRAFT VERSUS HOST DISEASE	0.13171141	1.6302095974962767
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.6232720908558675
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.13053441	1.615641712327838
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.1302778	1.612465616309934
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.6081127025164863
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786000000003	1.6042974513668085
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.12915187	1.59852983130764
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.12859712	1.591663616951488
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.12856165	1.5912246000552053
17P11.2 MICRODUPLICATION SYNDROME	0.127700594	1.5805671956953118
TETRASOMY 9P	0.127650524	1.5799474726618503
USHER SYNDROME	0.12682065	1.5696760120532929
HSD10 DISEASE	0.12668632400000002	1.5680134413284537
LISSENCEPHALY, X-LINKED, 2	0.12645501000000003	1.565150437258911
SMITH-MAGENIS SYNDROME	0.126326214	1.5635563120778109
TONNE-KALSCHEUER SYNDROME; TOKAS	0.125881294	1.5580494782042835
BRUNNER SYNDROME; BRNRS	0.12551649	1.553534250692825
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.1251955	1.5495613148727592
KAPOSI SARCOMA	0.125	1.5471415854331416
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.5471415854331416
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.5471415854331416
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.5471415854331416
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.125	1.5471415854331416
IMMUNODEFICIENCY 25	0.125	1.5471415854331416
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.5471415854331416
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.12496516000000002	1.54671036613045
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.12295130000000001	1.521784553704527
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.12295130000000001	1.521784553704527
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.12237621	1.5146665884695927
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12167381399999999	1.5059729399812574
X-LINKED AGAMMAGLOBULINEMIA	0.1216603	1.5058056754101732
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.12149258000000002	1.5037297827165028
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.12125159999999999	1.500747141282441
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511916
MOHR-TRANEBJAERG SYNDROME	0.11965903000000001	1.481035691084735
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.119613294	1.480469610544324
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.11952466400000002	1.4793726252745887
FG SYNDROME TYPE 1	0.119509974	1.4791908051954685
MYCETOMA	0.1192983	1.4765708880118287
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11906773999999999	1.4737172163003287
COG8-CDG	0.11851840999999999	1.4669180860033209
TRISOMY XQ28	0.11851840999999999	1.4669180860033209
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.11788800399999999	1.4591154672968683
RABIES	0.11694683	1.447466431820641
INTESTINAL LYMPHANGIECTASIA	0.11666670000000001	1.443999225642022
ROLANDIC EPILEPSY	0.11662072999999998	1.4434302488525625
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.11515305399999999	1.4252646282642254
LIGNEOUS CONJUNCTIVITIS	0.11498661400000001	1.4232045783003897
WIEDEMANN-STEINER SYNDROME	0.11480911	1.421007587740544
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11463909400000001	1.418903277150232
GM2-GANGLIOSIDOSIS, AB VARIANT	0.114181954	1.4132451947153126
HENNEKAM-BEEMER SYNDROME	0.11411882000000001	1.4124637768204746
HADDAD SYNDROME	0.11374533	1.4078410415345273
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.11369860000000001	1.407262658124229
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.11350284400000002	1.4048397601386446
STEINERT MYOTONIC DYSTROPHY	0.11235632999999999	1.390649204237194
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.390296703498369
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189494999999999	1.384938642759697
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189494999999999	1.384938642759697
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.11165655399999999	1.3819879838364895
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.11165655399999999	1.3819879838364895
W SYNDROME	0.11165655399999999	1.3819879838364895
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.11126539400000002	1.3771465446160256
BEHÇET DISEASE	0.11125686000000001	1.377040918165705
TRACHEOBRONCHOMEGALY	0.11111099999999999	1.3752355895924944
CANDIDIASIS, FAMILIAL, 9; CANDF9	0.11111099999999999	1.3752355895924944
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.11111099999999999	1.3752355895924944
TURCOT SYNDROME WITH POLYPOSIS	0.11111099999999999	1.3752355895924944
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11111099999999999	1.3752355895924944
MOUNIER-KÜHN SYNDROME	0.11111099999999999	1.3752355895924944
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	1.3752355895924944
MUCKLE-WELLS SYNDROME	0.11111099999999999	1.3752355895924944
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.11111099999999999	1.3752355895924944
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.11111099999999999	1.3752355895924944
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11111099999999999	1.3752355895924944
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	1.3752355895924944
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	1.3752355895924944
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	0.11111099999999999	1.3752355895924944
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11111099999999999	1.3752355895924944
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924944
ULNAR-MAMMARY SYNDROME	0.11111099999999999	1.3752355895924944
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.1104094	1.3665517933017755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.110274644	1.3648839004098825
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.110026724	1.3618153616749977
22Q11.2 DELETION SYNDROME	0.109039514	1.349596532518554
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.10868672	1.3452299543706236
MOWAT-WILSON SYNDROME; MOWS	0.10818997000000001	1.3390816137101125
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.107255364	1.32751387124135
HURLER SYNDROME	0.107154724	1.326268236608086
DISTAL MONOSOMY 12Q	0.10715121400000001	1.326224792872367
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.10698568400000001	1.324176006099273
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.106466654	1.317751902922574
HUNTINGTON DISEASE-LIKE 1	0.1063492	1.3162981591803702
TRICHOHEPATOENTERIC SYNDROME 1	0.10633490000000001	1.3161211661829968
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.10601279999999999	1.3121344917456523
YOUNG SYNDROME	0.1059783	1.311707480668073
YOUNG SYNDROME	0.1059783	1.311707480668073
DEMENTIA, LEWY BODY; DLB	0.1055556	1.3064756666827724
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.10550188	1.3058107671150165
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10487747400000001	1.298082411204665
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.2947706123040195
KUFOR-RAKEB SYNDROME	0.10459870000000002	1.2946319884179647
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.10393371	1.2864013189547872
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.103693394	1.2834268959368273
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106442
NIEMANN-PICK DISEASE, TYPE C2	0.103502854	1.28106855707532
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.10349451400000001	1.28096533178874
HUNTINGTON DISEASE-LIKE 2	0.10330206	1.2785833030952762
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.1029843	1.2746503454137783
MYASTHENIA GRAVIS	0.1029573	1.2743161628313249
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.2694660596179823
SPINOCEREBELLAR ATAXIA TYPE 29	0.102450314	1.2680411298406655
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.10218380400000002	1.2647425002091954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.10179088400000001	1.2598792772352083
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.10179088400000001	1.2598792772352083
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.10173595400000002	1.2591994013369057
ACROMEGALY	0.10163245	1.257918318595636
SOMATOMAMMOTROPINOMA	0.10163245	1.257918318595636
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.10138595400000001	1.2548674048976927
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.101292234	1.2537074200225982
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.10101929000000001	1.2503291559194427
9P13 MICRODELETION SYNDROME	0.10091092	1.2489878460505355
47,XYY SYNDROME	0.10082483999999999	1.2479224224691425
NORRIE DISEASE	0.10058753	1.2449852051120296
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.10054555400000001	1.2444656625905086
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.10010446	1.2390061836266282
RING CHROMOSOME 22 SYNDROME	0.100070824	1.2385898663916872
COG4-CDG	0.10003916400000001	1.2381980063709288
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	1.2377132683465135
ACQUIRED ICHTHYOSIS	0.1	1.2377132683465135
IMMUNODEFICIENCY 28; IMD28	0.1	1.2377132683465135
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	1.2377132683465135
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.1	1.2377132683465135
IMMUNODEFICIENCY 30; IMD30	0.1	1.2377132683465135
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.1	1.2377132683465135
CHÉDIAK-HIGASHI SYNDROME	0.099597224	1.232728056352798
RAMOS-ARROYO SYNDROME	0.09920640000000001	1.2278907758489157
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.09837165400000002	1.2175590138499237
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059288
RAYNAUD-CLAES SYNDROME; MRXSRC	0.09646411399999999	1.1939491381709066
1P36 DELETION SYNDROME	0.095644934	1.1838100386192656
CHIARI MALFORMATION TYPE I	0.09545455000000001	1.181453630590457
ISOLATED AGAMMAGLOBULINEMIA	0.09450622	1.1697160243527465
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.09425988400000002	1.1666670909960324
IMMUNODEFICIENCY 36; IMD36	0.09421882000000001	1.1661588364195186
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302325
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.09361615400000001	1.1586995593737053
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09231673	1.1426164161136263
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.092069494	1.1395563433374971
DUANE RETRACTION SYNDROME 1	0.09180788000000001	1.136318312147645
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166454000000002	1.1345441739487974
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.1319147758815218
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.09136941399999998	1.1308913602884565
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0910973	1.1275233692054285
CONGENITAL ANALBUMINEMIA	0.0910816	1.127329048222298
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.09097247400000001	1.1259783812410824
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0909091	1.1251939928344004
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0909091	1.1251939928344004
PYOMYOSITIS	0.0909091	1.1251939928344004
PEMPHIGUS VULGARIS	0.0909091	1.1251939928344004
KERION CELSI	0.0909091	1.1251939928344004
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09074071000000002	1.1231098074618318
PSEUDOMYXOMA PERITONEI	0.09047619999999999	1.119835932095728
RHEUMATOID ARTHRITIS	0.0901315	1.1155695344597376
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.08982525000000001	1.1117790375754266
SCHIZOPHRENIA 1; SCZD1	0.08949280000000001	1.1076642598148088
8Q12 MICRODUPLICATION SYNDROME	0.08934333400000001	1.105814299301142
DUBOWITZ SYNDROME	0.08918935	1.1039084189020112
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.0961265442699362
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.0900867510630587
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.087859244	1.087445520456938
RIDDLE SYNDROME	0.087729554	1.0858403301192194
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100154
3Q29 MICRODELETION SYNDROME	0.086569634	1.0714838463770147
GABRIELE-DE VRIES SYNDROME	0.08629349	1.0680659754492716
FAMILIAL COLORECTAL CANCER TYPE X	0.08603924	1.0649190894645006
LYNCH SYNDROME	0.08603924	1.0649190894645006
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.08597524400000002	1.0641270024812899
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08584681999999999	1.0625374815935482
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	1.0606587566235253
NASU-HAKOLA DISEASE	0.08565881	1.06021045687773
SLC35A2-CDG	0.085630754	1.0598632040431628
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.08523363	1.0549479476033745
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.08496466	1.0516188702255027
LAFORA DISEASE	0.08479032	1.0494610409134675
15Q13.3 MICRODELETION SYNDROME	0.08475211400000002	1.0489881601821631
DUANE-RADIAL RAY SYNDROME; DRRS	0.08457863000000002	1.046840925695705
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534556
JACOBSEN SYNDROME	0.084319034	1.043627871559608
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853624
RETT SYNDROME, CONGENITAL VARIANT	0.08399551000000001	1.0396235720853226
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.08394523400000001	1.0390012993625286
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08387885400000002	1.0381797052950004
TOWNES-BROCKS SYNDROME 1; TBS1	0.08387885400000002	1.0381797052950004
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.08367273399999998	1.0356285307062842
CONGENITAL ENTEROVIRUS INFECTION	0.08363451000000001	1.0351554271865917
HEPATOCELLULAR CARCINOMA	0.0833334	1.0314285487642734
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08333330000000001	1.031427311051005
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08333330000000001	1.031427311051005
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.031427311051005
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08323697	1.0302350218596068
SIALURIA	0.08239893400000001	1.0198625390940865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08239476400000001	1.0198109264507966
SUSAC SYNDROME	0.0823679	1.0194784271583877
PHENYLKETONURIA	0.08224078000000001	1.0179050460516659
MEND SYNDROME	0.082207994	1.0174992493795059
NIJMEGEN BREAKAGE SYNDROME	0.08204898	1.015531112002977
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.0153791208136242
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.081913094	1.0138492329511517
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.08173713	1.0116713031756386
GLASS SYNDROME	0.08163030400000001	1.0103491035995948
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.080999154	1.0025372763064258
SPINOCEREBELLAR ATAXIA 12	0.08064715	0.9981804760933152
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.080202354	0.9926751769842406
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.08011995	0.9916552517425924
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.080067204	0.9910024075020704
CRANIOPHARYNGIOMA	0.079579164	0.9849618716672319
PRADER-WILLI SYNDROME; PWS	0.07914104400000001	0.9795392022959524
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.078964954	0.9773597130017209
KID SYNDROME	0.07861955999999999	0.9730847256356481
NEUTROPHIL CHEMOTACTIC RESPONSE	0.078235	0.9683249754908948
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07816843000000001	0.9675010297681567
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.07815333	0.967314135064636
FELTY SYNDROME	0.0770881	0.9541296420162286
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	0.9520874151234571
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	0.9520874151234571
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	0.9520874151234571
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0766806	0.9490859604477165
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07667009	0.9489558767832134
KLEEFSTRA SYNDROME	0.076331864	0.9447696087042157
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.07603724999999999	0.941123132135809
FRAXE INTELLECTUAL DISABILITY	0.07602131	0.9409258406408348
PRIMROSE SYNDROME; PRIMS	0.07586609	0.9390046621057073
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0753968	0.9331961975086841
SCHAAF-YANG SYNDROME; SHFYNG	0.075308034	0.9320975289489035
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.07502572	0.9286032911125038
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07495905	0.9277781076764972
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.07472353000000001	0.9248630453868876
SMITH-FINEMAN-MYERS SYNDROME	0.07451932000000001	0.9223355111215972
CASPASE 8 DEFICIENCY	0.0744048	0.9209180818866866
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.07423871400000001	0.9188624134278208
NIPAH VIRUS DISEASE	0.0739348	0.915100829525458
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.073923664	0.914962997775895
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.073306054	0.90731875685926
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07197415400000001	0.8908336538381529
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.07197415400000001	0.8908336538381529
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07197415400000001	0.8908336538381529
FAMILIAL THYROID DYSHORMONOGENESIS	0.07197415400000001	0.8908336538381529
ATHYREOSIS	0.07197415400000001	0.8908336538381529
THYROID ECTOPIA	0.07197415400000001	0.8908336538381529
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.07197415400000001	0.8908336538381529
THYROID HEMIAGENESIS	0.07197415400000001	0.8908336538381529
IMMUNODEFICIENCY 60; IMD60	0.07175926	0.8881738822872723
ALZHEIMER DISEASE 4	0.07142860000000001	0.8840812595941577
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.8840812595941577
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.8840812595941577
H SYNDROME	0.0714285	0.8840800218808894
XP22.13P22.2 DUPLICATION SYNDROME	0.07115972	0.8807532961582275
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524647
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.070695334	0.8750055290198838
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471943
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.069895644	0.8651076597842438
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875292
FLOATING-HARBOR SYNDROME	0.06907224000000001	0.8549162792241478
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06849176	0.8477316012440499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.06831606400000001	0.8455569885400961
WRINKLY SKIN SYNDROME	0.06796236400000001	0.8411791967099543
DE BARSY SYNDROME	0.06796236400000001	0.8411791967099543
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.06795380000000001	0.8410731989456531
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06791203	0.8405562061134646
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0677778	0.8388948235933632
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067604894	0.8367547430895959
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064404
SMITH-LEMLI-OPITZ SYNDROME	0.067351624	0.8336199866948547
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.067075814	0.8302062497294281
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.06704545	0.8298304304726275
EPISODIC ATAXIA TYPE 6	0.06704545	0.8298304304726275
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.06704545	0.8298304304726275
EPISODIC ATAXIA, TYPE 6	0.06704545	0.8298304304726275
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.06704545	0.8298304304726275
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.06704545	0.8298304304726275
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.06704545	0.8298304304726275
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002706
CILIARY DYSKINESIA, PRIMARY, 33	0.06682206	0.8270655028024682
MEIGE DISEASE	0.0666667	0.825142591468765
BULLOUS IMPETIGO	0.0666667	0.825142591468765
GLIOBLASTOMA	0.0666667	0.825142591468765
CRANIOECTODERMAL DYSPLASIA 1	0.0666667	0.825142591468765
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	0.825142591468765
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.0666667	0.825142591468765
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0666667	0.825142591468765
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	0.825142591468765
HAIM-MUNK SYNDROME	0.0666667	0.825142591468765
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	0.825142591468765
DESMOID TUMOR	0.0666667	0.825142591468765
FLOATING-HARBOR SYNDROME	0.06660574400000001	0.8243881309689118
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.06651470000000001	0.8232612673008785
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.06584025399999999	0.8149135596710458
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.065243944	0.8075329516805689
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06522877	0.80734514106923
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765598
22Q11.2 MICRODUPLICATION SYNDROME	0.06458355399999999	0.7993592170277352
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.7982359427281802
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	0.7959932062859363
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394996
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.7957008584119528
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.790445156560573
AUTOIMMUNE HYPOPARATHYROIDISM	0.06370096	0.7884352339841052
MICROHYDRANENCEPHALY; MHAC	0.06349210000000001	0.7858501460518367
AMISH INFANTILE EPILEPSY SYNDROME	0.06346611	0.7855284643733935
KLEEFSTRA SYNDROME	0.06338615	0.7845387888440235
IMMUNODEFICIENCY 58; IMD58	0.06312092	0.7812560019423881
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.063045554	0.7803231869605661
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.7773084392443238
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06270057	0.7760532742188934
CILIARY DYSKINESIA DUE TO TRANSPOSITION OF CILIARY MICROTUBULES	0.0625	0.7735707927165708
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0625	0.7735707927165708
CILIARY DYSKINESIA, PRIMARY, 34; CILD34	0.0625	0.7735707927165708
DYSTONIA 12; DYT12	0.06247675	0.7732830243816803
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816803
LEGIONELLOSIS	0.0621118	0.7687659898088497
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701814
CENTRAL DIABETES INSIPIDUS	0.06203685	0.7678383237142239
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.061947140000000005	0.7667279711411904
13Q12.3 MICRODELETION SYNDROME	0.06185108	0.7655390237756167
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0618502	0.7655281318988553
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.06134204	0.7592385681544256
PERRY SYNDROME	0.060733920000000004	0.7517117862269569
ALG11-CDG	0.060614384	0.7502322732945061
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06052326	0.749104419455858
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.06047538	0.7485118023429738
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.06037801	0.7473066409335848
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215693
TURNPENNY-FRY SYNDROME; TPFS	0.059175664	0.7324250449601512
CHARGE SYNDROME	0.058998014	0.7302262473389336
1Q21.1 MICRODELETION SYNDROME	0.05892659400000001	0.7293422725226807
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0588235	0.7280662644058113
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0588235	0.7280662644058113
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0588235	0.7280662644058113
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0588235	0.7280662644058113
FANCONI-LIKE SYNDROME	0.0588235	0.7280662644058113
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.05881001	0.7278992968859114
16P13.11 MICRODELETION SYNDROME	0.057663814	0.7137126769126544
N-ACETYLASPARTATE DEFICIENCY; NACED	0.057651204000000005	0.7135566012695159
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.057621950000000005	0.7131945206299939
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.057621950000000005	0.7131945206299939
WOLFRAM SYNDROME	0.057531979999999996	0.7120809500024624
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.057407410000000006	0.7105391305840832
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.057346484	0.7097850413982104
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.057325444	0.7095246265265504
MEDULLOBLASTOMA	0.057256964	0.7086770404803866
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267634
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.057005480000000004	0.7055643896446181
ALEXANDER DISEASE	0.05690614	0.7043348452838426
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363915
BABESIOSIS	0.05660889	0.7006557425936826
MIETENS SYNDROME	0.056400784	0.6980799870194575
PFAPA SYNDROME	0.056390930000000006	0.6979580227539947
RHEUMATIC FEVER	0.056390930000000006	0.6979580227539947
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.056390930000000006	0.6979580227539947
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05607038	0.6939905328723098
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539003
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	0.6876190325095156
BENIGN OCCIPITAL EPILEPSY	0.055555600000000004	0.6876190325095156
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	0.6876190325095156
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	0.6876190325095156
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504074
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091228
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.055155454	0.6826663723747578
FILIPPI SYNDROME	0.055155454	0.6826663723747578
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.055155454	0.6826663723747578
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.055155454	0.6826663723747578
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.055155454	0.6826663723747578
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.055155454	0.6826663723747578
HYPERTRICHOSIS CUBITI	0.055155454	0.6826663723747578
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05509279	0.6818907717322811
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05482505	0.6785769182276102
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0546318	0.6761850373365306
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.054620810000000006	0.6760490126483393
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307626
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307626
HYDROXYKYNURENINURIA	0.054333154	0.6724886561691444
KAWASAKI DISEASE	0.05433041	0.672454693317061
48,XXYY SYNDROME	0.054230334000000005	0.6712160393866305
1Q21.1 MICRODUPLICATION SYNDROME	0.05379041400000001	0.6657710911765207
LICHTENSTEIN SYNDROME	0.05378683000000001	0.665726731532983
DISTAL MONOSOMY 7Q36	0.053626230000000004	0.6637389640240186
SIMPSON-GOLABI-BEHMEL SYNDROME	0.053557604	0.662889570916483
BIOTINIDASE DEFICIENCY	0.053177154	0.6581806907870587
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.053016624	0.6561937896773821
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.053012050000000005	0.6561371766724879
OCULOCEREBRORENAL SYNDROME OF LOWE	0.05290303	0.6547878216673364
SCHINZEL-GIEDION SYNDROME	0.052810850000000006	0.6536468975765748
MUCOPOLYSACCHARIDOSIS, TYPE II	0.05274751	0.652862929992404
KEUTEL SYNDROME; KTLS	0.05273756	0.6527397775222036
IMMUNODEFICIENCY 15A; IMD15A	0.0526316	0.6514282965430636
PARKINSON DISEASE, LATE-ONSET; PD	0.052499420000000005	0.6497922871449632
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.052450314000000005	0.649184495667409
RETT SYNDROME; RTT	0.05216591	0.6456643896237008
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.05216445	0.6456463190099828
ECTODERMAL DYSPLASIA SYNDROME	0.05216445	0.6456463190099828
GIANT CELL ARTERITIS	0.05206344	0.644396104837626
HUNTINGTON DISEASE; HD	0.05203684	0.6440668731082458
ENCEPHALITIS LETHARGICA	0.05161783	0.6388807307425471
GANGLIOCYTOMA	0.0514889	0.6372849470256678
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.05112156	0.6327383311057239
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05092595999999999	0.630317363952838
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.050741884	0.6280390308769965
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.050741884	0.6280390308769965
AMYOTROPHIC LATERAL SCLEROSIS	0.050723950000000004	0.6278170593794513
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.050545554	0.6256090284172519
DEXTROCARDIA	0.050545554	0.6256090284172519
HISTIDINEMIA	0.05043863	0.624285615882205
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.050368090000000004	0.6234125329427134
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.05028286999999999	0.6223577536954285
15Q24 MICRODELETION SYNDROME	0.050267414	0.6221664527326729
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726196
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.050100484	0.620100337973822
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.05	0.6188566341732568
NUT MIDLINE CARCINOMA	0.05	0.6188566341732568
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.05	0.6188566341732568
PLATELET DISORDER, UNDEFINED	0.05	0.6188566341732568
SCHWARTZ-JAMPEL SYNDROME	0.04993078	0.6179998890489073
OROMANDIBULAR DYSTONIA	0.04989894	0.6176058011442658
DESANTO-SHINAWI SYNDROME	0.049881454000000006	0.6173893746021627
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.049824363999999996	0.6166827640972636
MENINGIOMA	0.049802	0.6164059619019305
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.04952376	0.6129621485040833
USHER SYNDROME TYPE 1	0.049408904000000003	0.6115405605525912
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.049288894	0.6100551808592486
AICARDI SYNDROME	0.04907410999999999	0.6073967707929631
NEUROFIBROMATOSIS TYPE 1	0.048942780000000005	0.6057712819576437
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085961
USHER SYNDROME TYPE 3	0.04886335	0.6047881663085961
MICROPHTHALMIA, SYNDROMIC 1	0.048487810000000006	0.6001400579006476
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.048405673999999996	0.5991234497305584
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	0.5987822864452713
ALSTRÖM SYNDROME	0.048208614	0.5966844119639548
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04773568000000001	0.590830845095433
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.047658454	0.5898750086468196
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.047619	0.5893866812539262
LUJO HEMORRHAGIC FEVER	0.047619	0.5893866812539262
EBOLA HEMORRHAGIC FEVER	0.047619	0.5893866812539262
LYMPHOKINE DEFICIENCY	0.047619	0.5893866812539262
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.047619	0.5893866812539262
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.047619	0.5893866812539262
LASSA FEVER	0.047619	0.5893866812539262
MARBURG HEMORRHAGIC FEVER	0.047619	0.5893866812539262
MONOCYTE CHEMOTACTIC DISORDER	0.047619	0.5893866812539262
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.047619	0.5893866812539262
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.047619	0.5893866812539262
ADULT-ONSET STILL DISEASE	0.047619	0.5893866812539262
HALLERMANN-STREIFF SYNDROME; HSS	0.04749835	0.5878933801956662
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.047475624	0.5876120974783018
MICROTRIPLICATION 11Q24.1	0.04735926	0.586171844810723
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04735926	0.586171844810723
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.047165953999999996	0.5837792708002131
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.047009850000000006	0.5818471508797934
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.046000054	0.569348771804561
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.04592227	0.5683860289159104
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045867254	0.567705088584197
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	0.5670311042010515
WHIM SYNDROME	0.0456402	0.5648948110998854
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.562596377560566
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.562596377560566
LITHIUM TRANSPORT	0.0454545	0.562596377560566
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.045287384	0.560527960655036
CD8 DEFICIENCY, FAMILIAL	0.04507352	0.5578809375508194
WHITE FORELOCK WITH MALFORMATIONS	0.04472363000000001	0.5535503025962019
HAMAMY SYNDROME; HMMS	0.044678749999999996	0.5529948168813679
8P INVERTED DUPLICATION/DELETION SYNDROME	0.044546199999999994	0.5513542279441744
LYME DISEASE	0.04454545	0.5513449450946619
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04448623	0.5506119712971472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.04418211	0.5468478377054516
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.04414605	0.546401518300886
SLC39A8-CDG	0.04367104000000001	0.5405222565049133
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.04362747	0.5399829848338947
COFFIN-LOWRY SYNDROME	0.043570540000000005	0.539278354670225
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.5381366879515022
JUVENILE XANTHOGRANULOMA	0.043478300000000004	0.5381366879515022
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	0.5381366879515022
EOSINOPHILIA, FAMILIAL	0.043478300000000004	0.5381366879515022
COMMON VARIABLE IMMUNODEFICIENCY	0.043478300000000004	0.5381366879515022
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	0.5381366879515022
COMPLEMENT COMPONENT C1R DEFICIENCY	0.043478300000000004	0.5381366879515022
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.5381366879515022
242680 CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA;;IMMOTILE CILIA SYNDROME DUE TO EXCESSIVELY LONG CILIA	0.043478300000000004	0.5381366879515022
HYPOPLASMINOGENEMIA	0.043478300000000004	0.5381366879515022
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	0.5381366879515022
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	0.5381366879515022
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.5381366879515022
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.5381366879515022
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.5381366879515022
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.5381366879515022
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	0.5381366879515022
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.043447884	0.5377602250838018
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.04331429	0.536106714420087
HARTNUP DISEASE	0.043299144	0.5359192503684632
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	0.5337231262079054
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.042986720000000006	0.5320523370669644
16P13.11 MICRODUPLICATION SYNDROME	0.042791624	0.529637607988951
KEPPEN-LUBINSKY SYNDROME	0.042768509999999996	0.5293515229441054
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.042621094000000005	0.5275269355524398
OGDEN SYNDROME	0.042527114	0.5263637326228476
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.04250626	0.5261056198978666
FETAL HYDANTOIN SYNDROME	0.042267084	0.5231453068111662
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.522827412535324
CORNELIA DE LANGE SYNDROME	0.04205355	0.5205023681607351
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.04182724	0.5177012992631402
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.041711279999999996	0.5162660469571655
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	0.5157142743821367
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821367
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.041666699999999994	0.5157142743821367
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	0.5157142743821367
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	0.5157142743821367
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821367
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0416666	0.5157130366688684
MYELOLYMPHATIC INSUFFICIENCY	0.0414764	0.5133589060324733
CERNUNNOS-XLF DEFICIENCY	0.0414764	0.5133589060324733
IMMUNE DEFICIENCY DISEASE	0.0414764	0.5133589060324733
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.041419823999999994	0.5126586573737735
MILD CANAVAN DISEASE	0.04140924	0.5125276578014518
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.041259699999999996	0.5106767813799664
SHUKLA-VERNON SYNDROME; SHUVER	0.041107004	0.508786842727732
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264552
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.040634180000000006	0.5029346373438054
WILSON DISEASE	0.0406015	0.5025301526477096
MERCURY POISONING	0.04	0.4950853073386054
TYPHOID	0.04	0.4950853073386054
BUERGER DISEASE	0.04	0.4950853073386054
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.4950853073386054
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.03997337	0.49475570429524474
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.49469790308561284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.03975635400000001	0.4920696684688099
YOU-HOOVER-FONG SYNDROME; YHFS	0.039756354	0.49206966846880984
TRANSKETOLASE DEFICIENCY	0.039720034	0.49162013100974633
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.039648114	0.4907299676271515
HURLER SYNDROME	0.03964299400000001	0.4906665967078123
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.49061716243987435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.039366054	0.4872388735824533
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.039271904	0.4860735665403052
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.039210800000000004	0.48531727422481474
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.039210800000000004	0.48531727422481474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039210800000000004	0.48531727422481474
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.48465707796747864
FETAL ALCOHOL SYNDROME	0.039134214	0.4843693591411188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.039113079999999995	0.4841077808189864
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.039075413999999996	0.483641583739331
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.4823307958796213
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.4823307958796213
4Q21 MICRODELETION SYNDROME	0.03893063	0.48184957296088826
HYPERPROLINEMIA, TYPE I	0.038901064	0.48148363065596894
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.038842864	0.48076328153379116
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.038842864	0.48076328153379116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.038406874	0.47536697545512735
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.038376214	0.47498749256705225
XQ28 (MECP2) DUPLICATION	0.038337674	0.4745104778734315
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.038220104000000005	0.4730552983838366
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.47125561378312997
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.037762834	0.4673956069216684
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037684343999999995	0.46642412577734316
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.03761906	0.4656160970472359
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.037587914	0.4652305988726767
KEUTEL SYNDROME	0.037582614	0.4651650000694544
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0370879	0.45904185925108654
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.037037060000000004	0.45841260582545923
CILIARY DYSKINESIA, PRIMARY, 41; CILD41	0.037037060000000004	0.45841260582545923
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.037037060000000004	0.45841260582545923
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.037037060000000004	0.45841260582545923
IMMUNODEFICIENCY 20; IMD20	0.037037060000000004	0.45841260582545923
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.037037060000000004	0.45841260582545923
CILIARY DYSKINESIA, PRIMARY, 27; CILD27	0.037037060000000004	0.45841260582545923
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.037037060000000004	0.45841260582545923
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.036939524	0.4572053898120447
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.036926643999999995	0.4570459723430816
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.036926643999999995	0.4570459723430816
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.036915784	0.45691155668213923
PITUITARY APOPLEXY	0.03680355	0.45552242157254325
BAKER-GORDON SYNDROME; BAGOS	0.036708684000000005	0.4543482525033937
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.036559193999999996	0.45249799493854237
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.03655809	0.4524843305840599
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.036547914	0.4523583808818729
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.036487714000000004	0.4516132774943284
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.036430540000000004	0.450905627310284
2Q37 MICRODELETION SYNDROME	0.036427664	0.4508700306766863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.036340774	0.44979458161781993
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.036275310000000005	0.4489843250038297
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036259854	0.448793024041074
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.448793024041074
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.036157744000000006	0.44752919502276545
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.036116034	0.447012944818538
COFS SYNDROME	0.03597881	0.44531450516318216
CLASSIC HOMOCYSTINURIA	0.035857700000000006	0.4438155106238878
OCHOA SYNDROME	0.0357928	0.4430122347127309
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	0.44204062979707887
ZELLWEGER SYNDROME	0.035714300000000004	0.44204062979707887
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	0.44204062979707887
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	0.44204062979707887
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	0.44204062979707887
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	0.44204062979707887
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0357143	0.44204062979707875
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.03567798	0.4415910923380154
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.035664554	0.44142491695460717
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.035513753999999995	0.4395584453459406
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.43938301186728523
CUSHING SYNDROME	0.035376540000000005	0.4378601294619118
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.035335934	0.43735754361216683
CHOREOACANTHOCYTOSIS	0.03531859	0.43714287462290485
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.03531276	0.4370707159393602
ISOTRETINOIN-LIKE SYNDROME	0.03527015	0.43654332631571774
SMITH-MAGENIS SYNDROME	0.03502418	0.4334989229895659
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03494899	0.43256828638309613
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.034800074	0.43072513329240525
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.034781494	0.43049516616714645
CHROMOSOME 10Q26 DELETION SYNDROME	0.034750784	0.4301150644224373
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03473354	0.4299016331464436
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.034732544000000004	0.4298893055222909
MYOCLONIC-ASTASTIC EPILEPSY	0.034723604	0.42977865395610065
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.034708414	0.4295906453106388
SHORT SYNDROME	0.03432861	0.4248897608089281
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.034162859999999996	0.42283825106664363
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.034110344	0.42218825356663886
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.033985129999999995	0.4206384632748114
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.4206264574561085
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.033807874	0.4184445422438712
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.033662404	0.41664404075240746
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.033573954	0.415549283366555
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03350343	0.4146763984611863
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	0.4146763984611863
OCULODENTODIGITAL DYSPLASIA	0.03350343	0.4146763984611863
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033440584	0.41389854518056124
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.033374334	0.4130785601402816
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.4128770109116641
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.0332735	0.41183052434327716
JOUBERT SYNDROME 1	0.033062694000000004	0.40922135051080666
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03302721	0.4087821603346665
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.40864143233605543
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.032994344	0.40837537349189174
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.40601517806048176
DISTAL MONOSOMY 10Q	0.032783364	0.40576404603833427
FRAGILE X SYNDROME	0.03276267	0.4055079136545826
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534614
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.032547964	0.40285046900464655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.03251714	0.4024689562668114
NEPHRONOPHTHISIS 11; NPHP11	0.032508383999999994	0.40236058209303494
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.03245731	0.40172843241835976
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.032431254	0.40140593384915935
AMYLOIDOSIS	0.03242385	0.40131429355877096
SECKEL SYNDROME 2; SCKL2	0.0322581	0.3992627838164866
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.3992627838164866
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	0.3992627838164866
HYPER-BETA-ALANINEMIA	0.0322581	0.3992627838164866
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.3992627838164866
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	0.3992627838164866
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	0.3992627838164866
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.3992627838164866
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.3992627838164866
SECKEL SYNDROME	0.0322581	0.3992627838164866
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.3992627838164866
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.3992627838164866
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	0.3992627838164866
DYSTONIA, JUVENILE-ONSET	0.0322581	0.3992627838164866
COG1-CDG	0.0322581	0.3992627838164866
DEND SYNDROME	0.0322581	0.3992627838164866
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.3992627838164866
DENT DISEASE	0.0322581	0.3992627838164866
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.032233834	0.39896244031478967
HURLER-SCHEIE SYNDROME	0.03216852	0.39815404027070184
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.032131454	0.3976952694706565
WHIPPLE DISEASE	0.03209902	0.397293829549201
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.032047244	0.39665299112738195
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03204225	0.39659117972676067
AICARDI-GOUTIERES SYNDROME 7	0.032030064000000004	0.3964403519878801
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.03195696	0.39553553408018793
OBESITY DUE TO SIM1 DEFICIENCY	0.031952244	0.39547716352245266
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.031920474	0.395083942017099
20Q11.2 MICRODUPLICATION SYNDROME	0.031778164	0.3933225522649151
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.031664	0.39190952928923994
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.031601434	0.3911351416057663
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03158345	0.39091255125158686
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.03158345	0.39091255125158686
CLASSIC PHENYLKETONURIA	0.031581224000000005	0.3908849997542336
WHIM SYNDROME	0.0315557	0.3905690858196207
SECKEL SYNDROME 9; SCKL9	0.031432074	0.38903895041449466
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.03137492	0.3883315477731039
HELSMOORTEL-VAN DER AA SYNDROME	0.031342704	0.3879328060665734
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03133789	0.3878732225498352
2Q23.1 MICRODUPLICATION SYNDROME	0.031320504000000006	0.38765803372100055
TRISOMY 13	0.03121691	0.3863758370377896
MEHMO SYNDROME	0.03121691	0.3863758370377896
15Q11Q13 MICRODUPLICATION SYNDROME	0.031086044	0.38475609119203524
ALSTROM SYNDROME; ALMS	0.031080303999999996	0.3846850464504321
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.031066464000000002	0.384513746934093
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.3843827473617712
MENTAL RETARDATION, X-LINKED 21	0.031014879999999998	0.3838752849217491
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.03100006	0.3836918558153802
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.03082924	0.38157759401039065
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.3807235718552316
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.3807235718552316
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.030704254	0.3800306257048151
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	0.3794473657042394
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.030657129999999998	0.3794473657042394
COSTELLO SYNDROME; CSTLO	0.030362284	0.3757980176410505
CONGENITAL DISORDER OF GLYCOSYLATION	0.030362284	0.3757980176410505
TETRASOMY X	0.030362284	0.3757980176410505
PENTASOMY X	0.030362284	0.3757980176410505
HARTNUP DISORDER	0.030137654000000003	0.37301774232636375
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.030060534	0.3720632178538149
MENTAL RETARDATION, X-LINKED 98; MRX98	0.030060534	0.3720632178538149
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0300522	0.3719600668300309
ISOLATED CEREBELLAR AGENESIS	0.03004853	0.37191464275308256
NEUROFERRITINOPATHY	0.03004853	0.37191464275308256
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.030011443999999998	0.37145562441038354
6Q16 MICRODELETION SYNDROME	0.029968693999999997	0.3709265019881654
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	0.37078614530353493
NAVAJO NEUROHEPATOPATHY	0.029957354	0.37078614530353493
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.029894513999999997	0.370008366285706
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.02984282	0.36936854278876696
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.029833174	0.36924915296690225
DOWN SYNDROME	0.02981673	0.3690456233970554
C SYNDROME	0.02981673	0.3690456233970554
QAZI-MARKOUIZOS SYNDROME	0.029649850000000002	0.3669801274948387
LEIGH SYNDROME; LS	0.029644084	0.36690876094778585
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.029644083999999998	0.3669087609477858
MIRAGE SYNDROME; MIRAGE	0.029628753999999997	0.3667190195037483
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.029581304	0.36613172455791787
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.02943871	0.36436681970005186
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	0.3640337510595398
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	0.3640337510595398
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	0.3640337510595398
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	0.3640337510595398
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	0.3640337510595398
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	0.3640337510595398
MYELOPEROXIDASE DEFICIENCY	0.0294118	0.3640337510595398
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	0.3640337510595398
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	0.3640337510595398
MONOMELIC AMYOTROPHY	0.0294118	0.3640337510595398
RAGWEED SENSITIVITY	0.0294118	0.3640337510595398
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	0.3640337510595398
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	0.3640337510595398
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	0.3640337510595398
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	0.3640337510595398
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	0.3640337510595398
ECHO VIRUS 11 SENSITIVITY	0.0294118	0.3640337510595398
MYASTHENIA GRAVIS; MG	0.0294118	0.3640337510595398
IMMUNE SUPPRESSION	0.0294118	0.3640337510595398
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.0293714	0.36353371489912784
ASPARTYLGLUCOSAMINURIA; AGU	0.029311379999999998	0.36279083939546625
17Q21.31 MICRODUPLICATION SYNDROME	0.029181284	0.36118062394187816
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.029116954	0.3603844029963509
PROPIONIC ACIDEMIA	0.029116954	0.3603844029963509
ALG1-CDG	0.029116954	0.3603844029963509
GALLOWAY-MOWAT SYNDROME	0.029116954	0.3603844029963509
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029116954	0.3603844029963509
COFFIN-SIRIS SYNDROME 7; CSS7	0.029083903999999997	0.35997533876116233
PROGRESSIVE SUPRANUCLEAR PALSY	0.029076499999999998	0.35988369847077395
CORNELIA DE LANGE SYNDROME 1	0.02901857	0.3591666911744208
WIEACKER-WOLFF SYNDROME	0.028931114	0.35808423665845573
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.028911904000000002	0.35784647193960634
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02873829	0.3556976284258992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.028737334	0.3556857958870538
ADIPOSIS DOLOROSA	0.028665130000000004	0.354792117398777
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.35363200875235573
DYSOSTEOSCLEROSIS	0.0285714	0.35363200875235573
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	0.35363200875235573
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	0.35363200875235573
ALPHA-THALASSEMIA	0.0285714	0.35363200875235573
CHERUBISM	0.0285714	0.35363200875235573
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.35363200875235573
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.35363200875235573
ACRODYSOSTOSIS	0.0285714	0.35363200875235573
ALG12-CDG	0.0285714	0.35363200875235573
SCHEIE SYNDROME	0.0285714	0.35363200875235573
ACHONDROPLASIA	0.0285714	0.35363200875235573
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.35363200875235573
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	0.35363200875235573
CONGENITAL LOBAR EMPHYSEMA	0.0285714	0.35363200875235573
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.35363200875235573
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	0.35363200875235573
COG7-CDG	0.0285714	0.35363200875235573
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	0.35363200875235573
CHEILITIS GLANDULARIS	0.0285714	0.35363200875235573
TOXIC EPIDERMAL NECROLYSIS	0.028550769999999996	0.3533766685050958
WYBURN-MASON SYNDROME	0.028533564	0.35316370756014415
DUPLICATION OF THE PITUITARY GLAND	0.028323354000000002	0.35056191049875296
HEREDITARY FOLATE MALABSORPTION	0.028299203999999998	0.3502630027444472
SALT-AND-PEPPER SYNDROME	0.028297364000000002	0.3502402288203097
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.02824098	0.3495423565710852
HYPERLYSINEMIA, TYPE I	0.02822056	0.3492896155216888
7Q11.23 DUPLICATION SYNDROME	0.02822056	0.3492896155216888
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.34817072272710364
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.02798801	0.346411313316149
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.02798801	0.346411313316149
COFFIN-SIRIS SYNDROME 8; CSS8	0.02797498	0.34625003927728343
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.027926644	0.3456517781918955
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.027851554	0.3447223792986941
RICHARDS-RUNDLE SYNDROME; RRNS	0.027806823999999997	0.3441687501537627
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.027777800000000002	0.3438095162547578
CILIARY DYSKINESIA, PRIMARY, 24; CILD24	0.027777800000000002	0.3438095162547578
CILIARY DYSKINESIA, PRIMARY, 25; CILD25	0.027777800000000002	0.3438095162547578
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.027777800000000002	0.3438095162547578
%120050 COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S;;CB3S	0.027777800000000002	0.3438095162547578
IMMUNODEFICIENCY 24	0.027777800000000002	0.3438095162547578
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.027777800000000002	0.3438095162547578
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.3438095162547578
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.027751810000000002	0.34348783457631454
RABSON-MENDENHALL SYNDROME	0.027665164	0.342415405537823
MENTAL RETARDATION, X-LINKED 104; MRX104	0.027570624	0.34124527141392824
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.02740662	0.33921537214530917
SCIMITAR SYNDROME	0.02740662	0.33921537214530917
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.3375584453929737
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.3363082312206169
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.02711961	0.33566301129382786
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.33566301129382786
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.02711961	0.33566301129382786
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.02691445	0.3331237187524882
MAN1B1-CDG	0.026818604	0.3319374200933088
SARCOSINEMIA	0.026581164	0.3289985937089468
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.026564034000000004	0.3287865734260791
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.026554979999999995	0.3286745108667629
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.32850147855184814
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.32850147855184814
ALG13-CDG	0.02649091	0.32788150797573334
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.026345814000000002	0.3260856355318933
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.3257141482715318
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.3257141482715318
HUNTINGTON DISEASE-LIKE 2	0.0263158	0.3257141482715318
ALZHEIMER DISEASE 3; AD	0.0263158	0.3257141482715318
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.3257141482715318
ALZHEIMER DISEASE 10	0.0263158	0.3257141482715318
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.3257141482715318
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.02631175	0.3256640208841637
BARATELA-SCOTT SYNDROME	0.026295663999999996	0.3254649223278175
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.3240781388734314
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.026089900000000003	0.322918153998337
JUVENILE MYOCLONIC EPILEPSY	0.02601594	0.32200274126506795
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.025992633999999997	0.321714279810747
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.025960614	0.3213179640222225
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.32109017527231604
DISTAL TRISOMY 5Q	0.02571426	0.31826880787712014
DISTAL TRISOMY 6P	0.025600384	0.31685934951565786
RETT SYNDROME	0.02557119	0.3164980115040968
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.025545554	0.31618071133062353
OROFACIODIGITAL SYNDROME TYPE 4	0.025419274	0.3146177270153555
PEHO SYNDROME	0.025419274	0.3146177270153555
DUBOWITZ SYNDROME	0.025326019999999998	0.3134635098840916
AGEL AMYLOIDOSIS	0.02527774	0.31286594191813394
BILATERAL POLYMICROGYRIA	0.025210594000000003	0.3120348669669701
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.02518961	0.3117751452147402
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.025189414	0.3117727192967342
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.025140554	0.3111679725938201
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.025112464	0.31082029893674157
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.02510348	0.3107091027767133
CEREBROFACIOTHORACIC DYSPLASIA	0.02505483	0.31010695527166277
FREEMAN-SHELDON SYNDROME	0.02505483	0.31010695527166277
6P22 MICRODELETION SYNDROME	0.02505483	0.31010695527166277
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.025021579999999998	0.3096954156099375
SCHIZOPHRENIA 4	0.025	0.3094283170866284
SCHIZOPHRENIA 19; SCZD19	0.025	0.3094283170866284
SCHIZOPHRENIA 15; SCZD15	0.025	0.3094283170866284
MONILETHRIX	0.025	0.3094283170866284
HYPERPROLINEMIA TYPE 1	0.025	0.3094283170866284
MYOPATHY AND DIABETES MELLITUS	0.025	0.3094283170866284
MADRAS MOTOR NEURON DISEASE	0.025	0.3094283170866284
ACATALASEMIA	0.025	0.3094283170866284
CYSTINOSIS	0.024953649999999997	0.3088546369867497
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.3088546369867497
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.3088546369867497
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.024939353999999997	0.30867769349790686
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02487372	0.30786533277136036
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.02485322	0.3076116015513493
19P13.3 MICRODUPLICATION SYNDROME	0.024837964	0.3074227760151304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.024800864000000002	0.3069635843925739
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024800864000000002	0.3069635843925739
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.02476118	0.3064724102591632
TRISOMY 18P	0.02469528	0.30565675721532287
WHITE-SUTTON SYNDROME; WHSUS	0.024647314	0.30506307566902774
FRAGILE X MENTAL RETARDATION SYNDROME	0.02458615	0.3043060407255763
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.024553454	0.3039013579953577
16P11.2P12.2 MICRODELETION SYNDROME	0.024528943999999997	0.30359799447328595
CLEIDOCRANIAL DYSPLASIA	0.024430419999999998	0.30237854985278023
VASCULAR EHLERS-DANLOS SYNDROME	0.024390903999999998	0.3018894550776604
SULFOCYSTEINURIA	0.024355054	0.30144573487095827
DISTAL MONOSOMY 9P	0.024355054	0.30144573487095827
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024355054	0.30144573487095827
GERODERMA OSTEODYSPLASTICA	0.024355054	0.30144573487095827
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.024355054	0.30144573487095827
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024355054	0.30144573487095827
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024355054	0.30144573487095827
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.3002111901485787
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.024193434	0.2994453426866566
SCLERODERMA	0.024156530000000002	0.29898857698210607
GAUCHER DISEASE, PERINATAL LETHAL	0.023972629999999998	0.29671242228161676
SICKLE CELL ANEMIA	0.02395281	0.29646710751183053
ROIFMAN SYNDROME; RFMN	0.023889314000000002	0.2956812090949612
9Q33.3Q34.11 MICRODELETION SYNDROME	0.02382682	0.2949077125650407
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.2946933406269631
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0238095	0.2946933406269631
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0238095	0.2946933406269631
BRITTLE CORNEA SYNDROME	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.2946933406269631
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0238095	0.2946933406269631
HURLER-SCHEIE SYNDROME	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.2946933406269631
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0238095	0.2946933406269631
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0238095	0.2946933406269631
MUCOPOLYSACCHARIDOSIS TYPE 4	0.0238095	0.2946933406269631
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0238095	0.2946933406269631
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0238095	0.2946933406269631
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0238095	0.2946933406269631
SIALIDOSIS TYPE 1	0.0238095	0.2946933406269631
NON-DISTAL TRISOMY 13Q	0.0238095	0.2946933406269631
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.2946933406269631
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.023726913999999998	0.2936711627471664
JOUBERT SYNDROME 30; JBTS30	0.023726913999999998	0.2936711627471664
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.023343759999999998	0.288928814850966
ROIFMAN SYNDROME	0.023343759999999998	0.288928814850966
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.023293854	0.2883111216672651
KLEEFSTRA SYNDROME 2; KLEFS2	0.023246224	0.28772159883755155
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023181359999999998	0.2869187685031713
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.022917634	0.2836545968090918
2P15P16.1 MICRODELETION SYNDROME	0.022811543999999996	0.2823415068027029
TAY-SACHS DISEASE; TSD	0.0227273	0.2812988076369171
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.2812988076369171
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.2812988076369171
CAUDAL REGRESSION SEQUENCE	0.0227273	0.2812988076369171
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.2812988076369171
MEHMO SYNDROME; MEHMO	0.022720684	0.28121692052708336
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.022624184	0.2800225272231289
LOWRY-MACLEAN SYNDROME	0.02261456	0.2799034096981833
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.0225934	0.2796415095706012
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.022586794	0.2795597462320942
MOEBIUS SYNDROME; MBS	0.02257444	0.27940683913492265
CUTIS LAXA	0.022539323999999996	0.27897220374361004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.022473180000000002	0.278153530679395
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02243237	0.2776484198945828
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.02240255	0.2772793337979618
CK SYNDROME	0.022392774	0.2771583349488483
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.022392774	0.2771583349488483
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.27340281584150056
CROUZON SYNDROME	0.02207863	0.27327013297913383
SAETHRE-CHOTZEN SYNDROME	0.02207863	0.27327013297913383
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.2721526016691438
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.2721526016691438
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.2721526016691438
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.021822154	0.2700956954970094
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021822154	0.2700956954970094
CEDNIK SYNDROME	0.021822154	0.2700956954970094
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.021822154	0.2700956954970094
DYSTONIA 28, CHILDHOOD-ONSET	0.021822154	0.2700956954970094
PYRUVATE DEHYDROGENASE DEFICIENCY	0.021822154	0.2700956954970094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021822154	0.2700956954970094
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.2700956954970094
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.021757704	0.2692979892955601
PORPHYRIA	0.02173918	0.2690687152897316
ALPHA-MANNOSIDOSIS	0.021647523999999998	0.26793427681649584
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.021585954	0.26717221675717495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.021585954	0.26717221675717495
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.021585954	0.26717221675717495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.021585954	0.26717221675717495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.021585954	0.26717221675717495
INFANT BOTULISM	0.021532080000000002	0.26650541111098597
ATAXIA-TELANGIECTASIA	0.021509149999999998	0.26622160345855406
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.021418750000000004	0.2651027106639689
TYSHCHENKO SYNDROME	0.021378854	0.2646089125784293
OROFACIODIGITAL SYNDROME TYPE 14	0.021378854	0.2646089125784293
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.021341464	0.2641461315873946
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530143
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.2633433012530143
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0212766	0.2633433012530143
X-LINKED RETINOSCHISIS	0.0212766	0.2633433012530143
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.2633433012530143
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530143
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530143
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.2633433012530143
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0212766	0.2633433012530143
RAVINE SYNDROME	0.0212766	0.2633433012530143
3MC SYNDROME 1	0.0212766	0.2633433012530143
PRIMARY BASILAR INVAGINATION	0.0212766	0.2633433012530143
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.2633433012530143
JUVENILE ABSENCE EPILEPSY	0.0212766	0.2633433012530143
KURU, SUSCEPTIBILITY TO	0.0212766	0.2633433012530143
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530143
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.2633433012530143
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.02127535	0.2633278298371599
CUTANEOUS MASTOCYTOSIS	0.02127535	0.2633278298371599
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.021234193999999998	0.26281843656443926
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021215234	0.2625837661287607
TEMPLE SYNDROME	0.021135559999999998	0.2615976304593383
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.021118994	0.26139259087930405
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.021062763999999998	0.2606966247085128
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.020976494	0.25962884947191023
NEPHROGENIC DIABETES INSIPIDUS	0.020953753999999998	0.25934739347468827
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020953753999999998	0.25934739347468827
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.020953753999999998	0.25934739347468827
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020953753999999998	0.25934739347468827
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.02086915	0.2583002385411364
MORQUIO SYNDROME A	0.02086915	0.2583002385411364
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.02086915	0.2583002385411364
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.02086915	0.2583002385411364
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.2578565183344342
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.2578565183344342
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.2578565183344342
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.2578565183344342
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.2578565183344342
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.2578565183344342
APNEA, CENTRAL SLEEP	0.0208333	0.2578565183344342
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.2578565183344342
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.2578565183344342
UNIQUE GREEN PHENOMENON	0.0208333	0.2578565183344342
DERMOIDS OF CORNEA	0.0208333	0.2578565183344342
611426 TENTED EYEBROWS	0.0208333	0.2578565183344342
INFANTILE MYOFIBROMATOSIS	0.0208333	0.2578565183344342
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.2578565183344342
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.2578565183344342
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.2578565183344342
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344342
GLAUCOMA - SLEEP APNEA	0.0208333	0.2578565183344342
IMINOGLYCINURIA	0.0208333	0.2578565183344342
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.2578565183344342
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.2578565183344342
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.2578565183344342
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.2578565183344342
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.2578565183344342
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344342
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.2578565183344342
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.2578565183344342
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.2578565183344342
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.2578565183344342
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.2578565183344342
GAUCHER DISEASE, TYPE I	0.0208333	0.2578565183344342
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.2578565183344342
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.2578565183344342
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.2578565183344342
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.2578565183344342
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.2578565183344342
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.2578565183344342
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.2578565183344342
PUPIL, EGG-SHAPED	0.0208333	0.2578565183344342
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.2578565183344342
HYPOCHONDROPLASIA	0.0208333	0.2578565183344342
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.2578565183344342
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.2578565183344342
CRANDALL SYNDROME	0.0208333	0.2578565183344342
STICKLER SYNDROME, TYPE III	0.0208333	0.2578565183344342
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.2578565183344342
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.2578565183344342
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.2578565183344342
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.2578565183344342
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.2578565183344342
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.02079591	0.25739373734339943
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.020676729999999997	0.255918630670184
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.2558313718847656
MYHRE SYNDROME	0.020617114	0.2551807555281266
GAUCHER DISEASE, TYPE II	0.020574764	0.2546565839589818
FAMILIAL HYPERALDOSTERONISM TYPE I	0.020408199999999998	0.2525949992306931
PANHYPOPHYSITIS	0.020408199999999998	0.2525949992306931
TERATOMA, PINEAL	0.020408199999999998	0.2525949992306931
FAMILIAL COLD URTICARIA	0.020408199999999998	0.2525949992306931
PARATHYROID CARCINOMA	0.020408199999999998	0.2525949992306931
PRIMARY PARATHYROID HYPERPLASIA	0.020408199999999998	0.2525949992306931
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.020408199999999998	0.2525949992306931
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.2525949992306931
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.2525949992306931
NEPHRONOPHTHISIS 4	0.020408199999999998	0.2525949992306931
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.2525949992306931
NEPHRONOPHTHISIS 1	0.020408199999999998	0.2525949992306931
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.2525949992306931
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.020408199999999998	0.2525949992306931
FAMILIAL HYPERALDOSTERONISM TYPE III	0.020408199999999998	0.2525949992306931
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.2525949992306931
HELIX SYNDROME; HELIX	0.020408199999999998	0.2525949992306931
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.2525949992306931
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.020407093999999997	0.25258131012194524
ANTISYNTHETASE SYNDROME	0.02026382	0.2508079888138544
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.020061544	0.24830439192317388
REACTIVE ARTHRITIS	0.01993005	0.2466768732380943
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.01993005	0.2466768732380943
HYPOTONIA-CYSTINURIA SYNDROME	0.019776354	0.24477455745317644
CHROMOSOME 18Q DELETION SYNDROME	0.019759299999999997	0.2445634778323926
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.01967875	0.2435664997947395
ANDROGEN INSENSITIVITY SYNDROME	0.01967875	0.2435664997947395
EMANUEL SYNDROME	0.019564074	0.24214713972713045
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01944866	0.24071864533560103
XQ25 MICRODUPLICATION SYNDROME	0.019429454	0.24048093012528238
CHROMOSOME 2Q37 DELETION SYNDROME	0.019369393999999998	0.23973755953631345
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019334784	0.23930918697413875
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.019334784	0.23930918697413875
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.019334784	0.23930918697413875
ISOLATED COMPLEX I DEFICIENCY	0.019334784	0.23930918697413875
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.019334784	0.23930918697413875
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.019334784	0.23930918697413875
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.019329434	0.23924296931428218
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.019245174	0.2382000721143734
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.23803874856697715
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.2380221632091813
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.2380221632091813
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0192308	0.2380221632091813
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.2380221632091813
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0192308	0.2380221632091813
248100 MACROSOMIA ADIPOSA CONGENITA	0.0192308	0.2380221632091813
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.2380221632091813
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.2380221632091813
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.2380221632091813
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.2380221632091813
NETHERTON SYNDROME; NETH	0.019161763999999998	0.23716769547724556
RIFT VALLEY FEVER	0.01903825	0.2356389463109801
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.01900676	0.2352491904027778
GOOD SYNDROME	0.01898172	0.2349392670003838
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.01898172	0.2349392670003838
IMMUNODEFICIENCY 50; IMD50	0.01898172	0.2349392670003838
PRUNE BELLY SYNDROME	0.01898172	0.2349392670003838
SEVERE COMBINED IMMUNODEFICIENCY	0.01898172	0.2349392670003838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01897984	0.23491599799093893
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.018942954	0.2344594550747766
OCCIPITAL HORN SYNDROME	0.018942203999999997	0.234450172225264
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.2343887321386233
RUBINSTEIN-TAYBI SYNDROME	0.018892884	0.23383973204131547
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.018616209999999998	0.2304153012332504
CADASIL	0.01852894	0.22933514886396447
TRIMETHYLAMINURIA	0.01852894	0.22933514886396447
JOUBERT SYNDROME 26	0.018402654	0.22777209028590042
BLADDER EXSTROPHY	0.01839665	0.22769777798126886
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.01839665	0.22769777798126886
HOLMES-GANG SYNDROME	0.018327754	0.22684504304790887
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.018327754	0.22684504304790887
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.018327754	0.22684504304790887
XP21 MICRODELETION SYNDROME	0.018279394	0.22624648491133648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.018126554	0.22435476395199563
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.018126554	0.22435476395199563
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.018126554	0.22435476395199563
HEART AND BRAIN MALFORMATION SYNDROME	0.018089454	0.22389557232943913
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	0.22389557232943913
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.018089454	0.22389557232943913
WILSON-TURNER SYNDROME	0.018089454	0.22389557232943913
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	0.22389557232943913
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.018089454	0.22389557232943913
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	0.22389557232943913
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018089454	0.22389557232943913
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	0.22389557232943913
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01798588	0.22261362318888187
AASE-SMITH SYNDROME	0.01791203	0.22169957194020798
GORLIN SYNDROME	0.01791203	0.22169957194020798
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.017912	0.2216992006262275
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.0178571	0.22101969604190527
LARYNGEAL WEB, FAMILIAL	0.0178571	0.22101969604190527
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.0178571	0.22101969604190527
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.0178571	0.22101969604190527
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0178571	0.22101969604190527
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0178571	0.22101969604190527
FAMILIAL NASAL ACILIA	0.0178571	0.22101969604190527
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.017841273999999997	0.2208238155400567
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.017834914	0.22074509697618988
UNILATERAL POLYMICROGYRIA	0.01778675	0.2201489647576235
19P13.12 MICRODELETION SYNDROME	0.017780143999999998	0.22006720141911645
DISTAL MONOSOMY 6P	0.017780143999999998	0.22006720141911645
CHROMOSOME 19P13.13 DELETION SYNDROME	0.017780143999999998	0.22006720141911645
LISSENCEPHALY 5; LIS5	0.017716709999999997	0.21928207038447353
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.017716709999999997	0.21928207038447353
HARLEQUIN ICHTHYOSIS	0.01768162	0.21884775679861077
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017647554	0.21842611739661585
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.017636304000000002	0.21828687465392688
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01761532	0.21802715290169705
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01761532	0.21802715290169705
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.01761532	0.21802715290169705
POSTORGASMIC ILLNESS SYNDROME	0.01760606	0.21791254065304816
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.017581	0.21760236970800054
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017566263999999998	0.21741998028077694
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017566263999999998	0.21741998028077694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544398
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544398
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0175439	0.21714317808544398
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544398
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544398
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0175439	0.21714317808544398
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544398
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.2167567640030662
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.017479994	0.21635220504417443
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017463274	0.21614525938570694
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.017460784	0.2161144403253251
MYOCLONIC EPILEPSY OF INFANCY	0.017460784	0.2161144403253251
1Q41Q42 MICRODELETION SYNDROME	0.01742467	0.2156674525555944
PRIMARY CILIARY DYSKINESIA	0.017406679999999997	0.21544478793861882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.017333094	0.2145340042529734
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.017295719999999997	0.21407142129606155
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.017286104	0.2139524027881774
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.017256203999999997	0.21358232652094175
MYOPATHY, CONGENITAL	0.0172414	0.21339909544869579
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.21339909544869579
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.21339909544869579
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.21339909544869579
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.21339909544869579
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.21339909544869579
THUMBS, CONGENITAL CLASPED	0.0172414	0.21339909544869579
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.21339909544869579
269800 SENILE PLAQUE FORMATION	0.0172414	0.21339909544869579
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.21339909544869579
CARDIAC ARRHYTHMIA	0.0172414	0.21339909544869579
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.21339909544869579
CERVICAL RIB	0.0172414	0.21339909544869579
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.21339909544869579
TRANSSEXUALITY	0.0172414	0.21339909544869579
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.21339909544869579
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.21339909544869579
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.21339909544869579
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.21339909544869579
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.21339909544869579
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.21339909544869579
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.21339909544869579
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.21339909544869579
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.21339909544869579
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.21339909544869579
PALMOMENTAL REFLEX	0.0172414	0.21339909544869579
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.21339909544869579
DIASTEMATOMYELIA	0.0172414	0.21339909544869579
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.21339909544869579
JUMPING FRENCHMAN OF MAINE	0.0172414	0.21339909544869579
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.21339909544869579
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.21339909544869579
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.21339909544869579
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.21339909544869579
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.21339909544869579
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.21339909544869579
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.21339909544869579
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.21339909544869579
ERYTHERMALGIA, PRIMARY	0.0172414	0.21339909544869579
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.21339909544869579
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.21339909544869579
MOSAIC TRISOMY 15	0.0172414	0.21339909544869579
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.21339909544869579
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.21339909544869579
MOTION SICKNESS	0.0172414	0.21339909544869579
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.21339909544869579
HOYERAAL-HREIDARSSON SYNDROME	0.017212254	0.21303835153950348
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	0.21303835153950348
FANCONI ANEMIA	0.017175483999999998	0.21258324437073245
CONGENITAL HYPOTHYROIDISM	0.017162484000000002	0.21242234164584747
TENORIO SYNDROME; TNORS	0.01714017	0.21214615830714859
EHLERS-DANLOS SYNDROME, TYPE VI	0.01709655	0.21160626777949584
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.017020709999999998	0.21066758603678185
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026911
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.01676216	0.20746747838147195
ACHROMATOPSIA	0.01674055	0.20720000854418225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.016736014	0.20714386587033007
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016736014	0.20714386587033007
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.2067934197355304
LANDAU-KLEFFNER SYNDROME	0.016686724	0.20653379700036203
CHOROIDAL OSTEOMA, BILATERAL	0.0166667	0.20628595729550833
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0166667	0.20628595729550833
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.20628595729550833
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.20628595729550833
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	0.20628595729550833
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	0.20628595729550833
117600 CEREBRAL SARCOMA	0.0166667	0.20628595729550833
PITYRIASIS RUBRA PILARIS	0.0166667	0.20628595729550833
ONCOCYTOMA	0.0166667	0.20628595729550833
ICHTHYOSIS, X-LINKED	0.0166667	0.20628595729550833
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.20628595729550833
HURIEZ SYNDROME; HRZ	0.0166667	0.20628595729550833
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.20628595729550833
N SYNDROME	0.0166667	0.20628595729550833
NASOPHARYNGEAL CARCINOMA	0.0166667	0.20628595729550833
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.20628595729550833
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.20628595729550833
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0166667	0.20628595729550833
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	0.20628595729550833
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.20628595729550833
THYMOMA, FAMILIAL	0.0166667	0.20628595729550833
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.20628595729550833
PRIMARY PERITONEAL CARCINOMA	0.0166667	0.20628595729550833
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0166667	0.20628595729550833
CHYLOUS ASCITES	0.0166667	0.20628595729550833
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	0.20628595729550833
ACQUIRED PURPURA FULMINANS	0.0166667	0.20628595729550833
PHEOCHROMOCYTOMA	0.0166667	0.20628595729550833
ADAMANTINOMA OF LONG BONES	0.0166667	0.20628595729550833
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	0.20628595729550833
HAND-FOOT-GENITAL SYNDROME	0.01662993	0.20583085012673735
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.01662993	0.20583085012673735
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185232
ANGELMAN SYNDROME	0.01652581	0.20454214307173493
MUENKE SYNDROME	0.016514624	0.2044036924655377
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062444
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.016266514000000003	0.2013328020754432
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.016237154	0.2009694094598566
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.016237154	0.2009694094598566
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.01619046	0.20039147162633492
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01619046	0.20039147162633492
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.01619046	0.20039147162633492
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.19963077305160914
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.01608196	0.1990485527301789
NETHERTON SYNDROME	0.016047474	0.19862171493245695
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.016047474	0.19862171493245695
IMMUNODEFICIENCY 23; IMD23	0.016047474	0.19862171493245695
17Q12 MICRODUPLICATION SYNDROME	0.015989259999999998	0.1979011925304217
MEIER-GORLIN SYNDROME 3; MGORS3	0.015989259999999998	0.1979011925304217
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01597067	0.1976711016338361
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.015930154	0.1971696297260328
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.015930154	0.1971696297260328
EVEN-PLUS SYNDROME	0.015930154	0.1971696297260328
JOUBERT SYNDROME 35; JBTS35	0.015930154	0.1971696297260328
CURRARINO SYNDROME	0.015930154	0.1971696297260328
611961 STEVENSON-CAREY SYNDROME	0.015930154	0.1971696297260328
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01588199	0.19657349750746642
HEREDITARY METHEMOGLOBINEMIA	0.01588199	0.19657349750746642
RING CHROMOSOME 7 SYNDROME	0.01588199	0.19657349750746642
DISTAL MONOSOMY 15Q	0.015871534	0.19644408220812812
ASPARTYLGLUCOSAMINURIA	0.01576031	0.1950674480025424
CHROMOSOME 16P13.3 DELETION SYNDROME	0.015748674	0.1949234276866376
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.01573813	0.19479292319962313
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.015731544	0.19471140740376983
MARFAN SYNDROME	0.01572291	0.19460454324018078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.015679574	0.19406816781821018
3P25.3 MICRODELETION SYNDROME	0.01567239	0.19397925049701215
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01565682	0.19378653854113054
BARDET-BIEDL SYNDROME 1; BBS1	0.015600443999999998	0.1930887653089675
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.015596684	0.1930422272900777
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.015596684	0.1930422272900777
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015544544	0.19239688359196186
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.01553103	0.19222961902087748
AORTIC ARCH DEFECTS	0.015501919999999999	0.19186932068846183
PRIMARY PULMONARY HYPOPLASIA	0.015501919999999999	0.19186932068846183
WEAVER SYNDROME	0.015479624	0.19159336013815131
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	0.0153846	0.1904172354820377
HARDIKAR SYNDROME	0.0153846	0.1904172354820377
UROFACIAL SYNDROME 2	0.0153846	0.1904172354820377
POLYCYSTIC KIDNEY DISEASE 2	0.0153846	0.1904172354820377
SCALP-EAR-NIPPLE SYNDROME	0.0153846	0.1904172354820377
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.0153846	0.1904172354820377
HINMAN SYNDROME	0.0153846	0.1904172354820377
CONGENITAL PRIMARY MEGAURETER	0.0153846	0.1904172354820377
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0153846	0.1904172354820377
UROFACIAL SYNDROME	0.0153846	0.1904172354820377
109820 BLADDER DIVERTICULUM	0.0153846	0.1904172354820377
PRIMARY HYPEROXALURIA TYPE 2	0.0153846	0.1904172354820377
PRIMARY HYPEROXALURIA TYPE 1	0.0153846	0.1904172354820377
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0153846	0.1904172354820377
SMALL CELL CARCINOMA OF THE BLADDER	0.0153846	0.1904172354820377
POSTERIOR URETHRAL VALVE	0.0153846	0.1904172354820377
VESICOURETERAL REFLUX 8; VUR8	0.0153846	0.1904172354820377
CONGENITAL MEGACALYCOSIS	0.0153846	0.1904172354820377
TRISOMY X	0.015380584	0.1903675289171809
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01532983	0.1897393399249643
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.015299293999999998	0.189361391801342
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.015213704000000002	0.18830203301496426
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.015213704	0.18830203301496423
LOEYS-DIETZ SYNDROME 3; LDS3	0.015207150000000001	0.18822091328735682
LOEYS-DIETZ SYNDROME 5	0.015207150000000001	0.18822091328735682
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01520312	0.18817103344264244
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.01518599	0.18795901315977467
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01493168	0.18481138454704268
CLASSICAL EHLERS-DANLOS SYNDROME	0.014916849999999999	0.18462783166934688
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.014831254	0.18356839862017302
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.18356839862017302
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.014702870000000002	0.18197937281773904
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.014664374	0.18150290271795635
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.014645414	0.18126823228227784
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.014645414	0.18126823228227784
SALLA DISEASE	0.014645414	0.18126823228227784
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.014645414	0.18126823228227784
CEREBROFACIOARTICULAR SYNDROME	0.014630054	0.1810781195242598
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.014630054	0.1810781195242598
PETTIGREW SYNDROME	0.014630054	0.1810781195242598
XQ25 DUPLICATION SYNDROME	0.014622804	0.1809883853123047
PIERPONT SYNDROME	0.014599554	0.18070061697741416
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.014503344000000001	0.17950981304193797
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014503344000000001	0.17950981304193797
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.014498514000000002	0.17945003149107683
MAPLE SYRUP URINE DISEASE; MSUD	0.0144928	0.17937930855492348
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492348
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492348
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	0.17937930855492348
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.014451974	0.17887399973598833
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014451974	0.17887399973598833
NIEMANN-PICK DISEASE, TYPE A	0.014451974	0.17887399973598833
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.014351354	0.17762861264537808
MENTAL RETARDATION, X-LINKED 91; MRX91	0.014351354	0.17762861264537808
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.014351354	0.17762861264537808
MACROCEPHALY/AUTISM SYNDROME	0.014299214000000001	0.17698326894726224
TIMOTHY SYNDROME; TS	0.014299214000000001	0.17698326894726224
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.014297614	0.17696346553496867
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.17685226937494042
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.17681600437617787
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0142857	0.17681600437617787
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0142857	0.17681600437617787
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.17681600437617787
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.17681600437617787
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.014244153999999998	0.17630178402171062
AMISH LETHAL MICROCEPHALY	0.01411882	0.1747505084739612
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01411882	0.1747505084739612
2Q24 MICRODELETION SYNDROME	0.01411882	0.1747505084739612
MELNICK-NEEDLES SYNDROME	0.01410171	0.17453873573374712
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.01409986	0.17451583803828272
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0140845	0.1743257252802647
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.1743257252802647
PULMONARY BLASTOMA	0.0140845	0.1743257252802647
MICROPHTHALMIA, LENZ TYPE	0.0140845	0.1743257252802647
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0140845	0.1743257252802647
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.1743257252802647
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0140845	0.1743257252802647
CRANIOECTODERMAL DYSPLASIA 4	0.0140845	0.1743257252802647
ROWLEY-ROSENBERG SYNDROME	0.0140845	0.1743257252802647
TRACHEOPATHIA OSTEOPLASTICA	0.0140845	0.1743257252802647
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0140845	0.1743257252802647
MASP2 DEFICIENCY	0.0140845	0.1743257252802647
AICARDI SYNDROME; AIC	0.0140845	0.1743257252802647
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.1743257252802647
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.1743257252802647
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.014059314	0.17401399481649893
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.014004943999999998	0.1733410501124989
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014004943999999998	0.1733410501124989
FOLATE MALABSORPTION, HEREDITARY	0.013968374	0.1728884183702646
SILVER-RUSSELL SYNDROME	0.013957790000000001	0.17275741879794282
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013916000000000001	0.17224017842310083
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.013866904	0.17163251071687338
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0138058	0.17087621840138295
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013753660000000001	0.1702308747032671
CYCLIC VOMITING SYNDROME	0.01375206	0.17021107129097354
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.013698599999999998	0.16954938977771547
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.013698599999999998	0.16954938977771547
IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	0.013698599999999998	0.16954938977771547
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.013698599999999998	0.16954938977771547
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.013698599999999998	0.16954938977771547
NEUTROPHIL ACTIN DYSFUNCTION	0.013698599999999998	0.16954938977771547
GRISCELLI SYNDROME, TYPE 2; GS2	0.013698599999999998	0.16954938977771547
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.013698599999999998	0.16954938977771547
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.013698599999999998	0.16954938977771547
COMPLEMENT FACTOR H DEFICIENCY	0.013698599999999998	0.16954938977771547
GLYCOGEN STORAGE DISEASE IB	0.013698599999999998	0.16954938977771547
INFANTILE SYSTEMIC HYALINOSIS	0.013698599999999998	0.16954938977771547
SPECIFIC GRANULE DEFICIENCY	0.013698599999999998	0.16954938977771547
X-LINKED SEVERE CONGENITAL NEUTROPENIA	0.013698599999999998	0.16954938977771547
IMMUNODEFICIENCY 33	0.013698599999999998	0.16954938977771547
SICKLE CELL ANEMIA	0.013698599999999998	0.16954938977771547
IMMUNODEFICIENCY 47	0.013698599999999998	0.16954938977771547
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01359558	0.1682742975686649
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.16635398543282529
STURGE-WEBER SYNDROME	0.013421220000000001	0.16611622071397594
MICROFORM HOLOPROSENCEPHALY	0.013150129999999998	0.16276090381481534
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.013052284	0.16154985089026905
10Q22.3Q23.3 MICRODELETION SYNDROME	0.013052284	0.16154985089026905
IMMUNODEFICIENCY 53; IMD53	0.01285638	0.1591251210890475
COFFIN-SIRIS SYNDROME 6; CSS6	0.012840904	0.1589335725836382
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.012759613999999999	0.15792743546779928
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.012759613999999999	0.15792743546779928
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.012759613999999999	0.15792743546779928
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.012740654	0.1576927650321208
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.1576927650321208
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.012740654	0.1576927650321208
CRANIOFRONTONASAL SYNDROME; CFNS	0.012740654	0.1576927650321208
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.012740654	0.1576927650321208
ELEJALDE DISEASE	0.012740654	0.1576927650321208
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.012740654	0.1576927650321208
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.012740654	0.1576927650321208
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.012617254000000001	0.15616542685898122
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012593754000000002	0.1558745642409198
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.012593754000000002	0.1558745642409198
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012593754000000002	0.1558745642409198
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012593754000000002	0.1558745642409198
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012516634000000002	0.15492003976837096
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012516634000000002	0.15492003976837096
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.012516634000000002	0.15492003976837096
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.1547974566462739
TUBEROUS SCLEROSIS-1	0.01250673	0.1547974566462739
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.1547974566462739
15Q14 MICRODELETION SYNDROME	0.012504614	0.1547712666335157
MENTAL RETARDATION, X-LINKED 90	0.012467574	0.15431281763892013
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012450353999999999	0.15409968341411084
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.012450353999999999	0.15409968341411084
OCULO-PALATO-CEREBRAL SYNDROME	0.012450353999999999	0.15409968341411084
LOCKED-IN SYNDROME	0.012369050000000001	0.1530933730184144
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.012369050000000001	0.1530933730184144
FAMILIAL DYSAUTONOMIA	0.012369050000000001	0.1530933730184144
PELIZAEUS-MERZBACHER DISEASE	0.012369050000000001	0.1530933730184144
MENTAL RETARDATION, X-LINKED 105; MRX105	0.01226843	0.15184798592780416
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.15094037078812567
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.15094037078812567
CATARACT 48; CTRCT48	0.0121951	0.15094037078812567
RHYNS SYNDROME; RHYNS	0.0121951	0.15094037078812567
LELIS SYNDROME	0.0121951	0.15094037078812567
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0121951	0.15094037078812567
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.15094037078812567
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0121951	0.15094037078812567
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.15094037078812567
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.0121951	0.15094037078812567
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.15094037078812567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.15094037078812567
FACIOCARDIOMELIC SYNDROME	0.0121951	0.15094037078812567
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0121951	0.15094037078812567
OROFACIODIGITAL SYNDROME TYPE 3	0.0121951	0.15094037078812567
JUBERG-MARSIDI SYNDROME	0.0121951	0.15094037078812567
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.012173774	0.15067641605651808
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012149239999999999	0.15037275548326193
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.012149239999999999	0.15037275548326193
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.012100183999999998	0.14976558286234187
C SYNDROME	0.012100183999999998	0.14976558286234187
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.012100183999999998	0.14976558286234187
ADAMS-OLIVER SYNDROME 2; AOS2	0.012100183999999998	0.14976558286234187
GLYCEROL KINASE DEFICIENCY; GKD	0.012100183999999998	0.14976558286234187
MARINESCO-SJOGREN SYNDROME; MSS	0.012100183999999998	0.14976558286234187
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.012100183999999998	0.14976558286234187
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692465
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692465
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692465
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692465
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692465
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692465
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.012048200000000002	0.14912216999692465
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692465
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692465
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.012048200000000002	0.14912216999692465
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.012048200000000002	0.14912216999692465
FRIED SYNDROME	0.011996304	0.1484798463191835
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.011996304	0.1484798463191835
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.011971080000000002	0.1481676455243758
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.011931484	0.14767756057864131
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.14734728917011572
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.14734728917011572
MASTOCYTOSIS	0.011904799999999998	0.14734728917011572
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.14734728917011572
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	0.14734728917011572
YAO SYNDROME	0.011904799999999998	0.14734728917011572
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.14734728917011572
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.14734728917011572
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.14734728917011572
BERNARD-SOULIER SYNDROME	0.011904799999999998	0.14734728917011572
CARCINOID SYNDROME	0.011904799999999998	0.14734728917011572
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.14734728917011572
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.14734728917011572
STÜVE-WIEDEMANN SYNDROME	0.011904799999999998	0.14734728917011572
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	0.14734728917011572
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.14734728917011572
CHILBLAIN LUPUS	0.011904799999999998	0.14734728917011572
TRANSALDOLASE DEFICIENCY	0.011904799999999998	0.14734728917011572
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.14734728917011572
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.14734728917011572
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.14734728917011572
ICHTHYOSIS VULGARIS	0.011904799999999998	0.14734728917011572
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.14734728917011572
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.14734728917011572
DERMATITIS, ATOPIC	0.011904799999999998	0.14734728917011572
MYOTONIA PERMANENS	0.011904799999999998	0.14734728917011572
2Q33.1 DELETION SYNDROME	0.011783980000000001	0.1458518839992995
MENKES DISEASE	0.011783980000000001	0.1458518839992995
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.145822302652186
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.01166479	0.14437665355475726
INTELLECTUAL DISABILITY, WOLFF TYPE	0.01166479	0.14437665355475726
HYPERTELORISM, TEEBI TYPE; TBHS	0.01163752	0.14403912914647915
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.011486630000000001	0.1421715435958711
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01145324	0.1417582711355702
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.14172745207518836
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.011450749999999999	0.14172745207518836
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.011449464	0.14171153508255743
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011411293999999999	0.14123909992802958
VICI SYNDROME	0.011389054000000001	0.14096383249714933
CHRONIC GRAFT VERSUS HOST DISEASE	0.01125686	0.13932764981919135
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.011247890000000002	0.13921662693902068
MONOSOMY 18P	0.011222244000000001	0.1388992029942205
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.011222244000000001	0.1388992029942205
TEMPLE SYNDROME	0.01116402	0.13817855682085844
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01116402	0.13817855682085844
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.01116402	0.13817855682085844
CLEFT LIP/PALATE	0.01116402	0.13817855682085844
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683453
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01115462	0.13806221177363387
KABUKI SYNDROME 1	0.011050144	0.13676909845939614
PELGER-HUET ANOMALY; PHA	0.011050144	0.13676909845939614
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.010965014	0.13571543315405277
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.010942024	0.1354308828736599
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.010942024	0.1354308828736599
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.010942024	0.1354308828736599
CHROMOSOME 5Q12 DELETION SYNDROME	0.010924894000000001	0.13521886259079213
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.010924894000000001	0.13521886259079213
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.010924894000000001	0.13521886259079213
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.010924894000000001	0.13521886259079213
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.010924894000000001	0.13521886259079213
PMM2-CDG	0.010924894000000001	0.13521886259079213
HAREL-YOON SYNDROME; HAYOS	0.010924894000000001	0.13521886259079213
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.010924894000000001	0.13521886259079213
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.01090391	0.1349591408385623
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.01090391	0.1349591408385623
HALL-RIGGS SYNDROME	0.01090391	0.1349591408385623
TEMPLE-BARAITSER SYNDROME	0.01090391	0.1349591408385623
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.01090391	0.1349591408385623
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01090391	0.1349591408385623
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01090391	0.1349591408385623
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.01090391	0.1349591408385623
WARBURG MICRO SYNDROME 2; WARBM2	0.01090391	0.1349591408385623
ALLAN-HERNDON-DUDLEY SYNDROME	0.01090391	0.1349591408385623
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.01090391	0.1349591408385623
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.010854853999999999	0.13435196821764223
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.010854853999999999	0.13435196821764223
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.010854853999999999	0.13435196821764223
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010854853999999999	0.13435196821764223
WARSAW BREAKAGE SYNDROME; WABS	0.010854853999999999	0.13435196821764223
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.010854853999999999	0.13435196821764223
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010854853999999999	0.13435196821764223
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010854853999999999	0.13435196821764223
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010854853999999999	0.13435196821764223
HYDROCEPHALUS, NORMAL-PRESSURE	0.010854853999999999	0.13435196821764223
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010854853999999999	0.13435196821764223
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010854853999999999	0.13435196821764223
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010854853999999999	0.13435196821764223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010854853999999999	0.13435196821764223
ADAMS-OLIVER SYNDROME 3; AOS3	0.010854853999999999	0.13435196821764223
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010854853999999999	0.13435196821764223
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.010854853999999999	0.13435196821764223
MEVALONIC ACIDURIA; MEVA	0.010854853999999999	0.13435196821764223
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010854853999999999	0.13435196821764223
CREE MENTAL RETARDATION SYNDROME	0.010854853999999999	0.13435196821764223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010854853999999999	0.13435196821764223
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010854853999999999	0.13435196821764223
ROSSELLI-GULIENETTI SYNDROME	0.010854853999999999	0.13435196821764223
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010854853999999999	0.13435196821764223
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010854853999999999	0.13435196821764223
GENITOPATELLAR SYNDROME; GTPTS	0.010854853999999999	0.13435196821764223
SEPTOOPTIC DYSPLASIA	0.010854853999999999	0.13435196821764223
PROPIONIC ACIDEMIA	0.010854853999999999	0.13435196821764223
REVESZ SYNDROME	0.010854853999999999	0.13435196821764223
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010854853999999999	0.13435196821764223
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.010854853999999999	0.13435196821764223
PYRUVATE CARBOXYLASE DEFICIENCY	0.010854853999999999	0.13435196821764223
ARIMA SYNDROME	0.010854853999999999	0.13435196821764223
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010854853999999999	0.13435196821764223
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010854853999999999	0.13435196821764223
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010854853999999999	0.13435196821764223
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010854853999999999	0.13435196821764223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010854853999999999	0.13435196821764223
GABA-TRANSAMINASE DEFICIENCY	0.010854853999999999	0.13435196821764223
CHROMOSOME 4Q21 DELETION SYNDROME	0.010854853999999999	0.13435196821764223
HARTSFIELD SYNDROME; HRTFDS	0.010854853999999999	0.13435196821764223
KRABBE DISEASE	0.010854084	0.13434243782547597
INFANTILE DYSTONIA-PARKINSONISM	0.010753464	0.13309705073486575
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.010753464	0.13309705073486575
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010753464	0.13309705073486575
COFFIN-SIRIS SYNDROME 5	0.010753464	0.13309705073486575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010753464	0.13309705073486575
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.010753464	0.13309705073486575
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.010753464	0.13309705073486575
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.010753464	0.13309705073486575
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.010753464	0.13309705073486575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.010753464	0.13309705073486575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.010737894	0.13290433877898414
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	0.1321468087502254
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.01053875	0.13043950706786817
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.01050459	0.13001670421540099
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.01050459	0.13001670421540099
SPINOCEREBELLAR ATAXIA TYPE 27	0.010429109999999998	0.12908247824045305
MONOSOMY 5P	0.01041946	0.12896303891005764
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.010407053999999999	0.12880948820198654
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010407053999999999	0.12880948820198654
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010407053999999999	0.12880948820198654
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01037934	0.128466468346797
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.01037934	0.128466468346797
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01037934	0.128466468346797
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.1275995739736471
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.1275995739736471
PIERSON SYNDROME	0.010309299999999999	0.1275995739736471
HYPOPHOSPHATASIA, INFANTILE	0.01030853	0.12759004358148085
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.010269014	0.12710094880636102
SYNDROMIC DIARRHEA	0.010269014	0.12710094880636102
OGDEN SYNDROME; OGDNS	0.010269014	0.12710094880636102
AARSKOG-SCOTT SYNDROME	0.010267414	0.12708114539406748
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010265464	0.12705700998533473
MUCOPOLYSACCHARIDOSIS TYPE 3	0.01025843	0.12696994923403923
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.010211004	0.1263829513393932
16Q24.3 MICRODELETION SYNDROME	0.01019234	0.126151944534989
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01001726	0.12398495614476795
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	0.12398495614476795
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01001726	0.12398495614476795
NANCE-HORAN SYNDROME	0.01001726	0.12398495614476795
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984134
COG5-CDG	0.0098615	0.12205709395799143
5Q14.3 MICRODELETION SYNDROME	0.0098615	0.12205709395799143
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009857724	0.12201035790497866
MUCOLIPIDOSIS IV; ML4	0.009832834	0.12170229107248721
LARSEN-LIKE SYNDROME	0.009804814	0.12135548381469652
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00972346	0.12034855456236589
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.009696694	0.12001726822896026
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.009607154	0.1189090197684828
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.009492564	0.11749072413428452
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.009492564	0.11749072413428452
MENTAL RETARDATION, X-LINKED 9	0.009492564	0.11749072413428452
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.009492564	0.11749072413428452
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.009492564	0.11749072413428452
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.009492564	0.11749072413428452
PITT-HOPKINS SYNDROME	0.00948117	0.11734969908448914
FABRY DISEASE	0.00937055	0.11598054066704422
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704422
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00937055	0.11598054066704422
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704422
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704422
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00937055	0.11598054066704422
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704422
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704422
SAGLIKER SYNDROME	0.00937055	0.11598054066704422
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704422
BETA-THALASSEMIA MAJOR	0.00937055	0.11598054066704422
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704422
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00937055	0.11598054066704422
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704422
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.11532373574406347
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.11532373574406347
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.11532373574406347
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.11532373574406347
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	0.11532373574406347
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.11532373574406347
ARGININEMIA	0.009317484000000001	0.11532373574406347
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.11532373574406347
INFANTILE REFSUM DISEASE	0.009317484000000001	0.11532373574406347
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	0.11532373574406347
MUCOLIPIDOSIS TYPE IV	0.00928728	0.11494989682849206
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00925926	0.11460308957070137
AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT	0.00925926	0.11460308957070137
NEUROFIBROMA	0.00925926	0.11460308957070137
OTITIS MEDIA, SUSCEPTIBILITY TO; OMS	0.00925926	0.11460308957070137
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00925926	0.11460308957070137
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00925926	0.11460308957070137
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00925926	0.11460308957070137
CILIARY DYSKINESIA, PRIMARY, 21; CILD21	0.00925926	0.11460308957070137
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00925926	0.11460308957070137
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575341
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009161724	0.11339587355728692
COFFIN-SIRIS SYNDROME 2; CSS2	0.009161724	0.11339587355728692
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.009161724	0.11339587355728692
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.009161724	0.11339587355728692
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009161724	0.11339587355728692
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009161724	0.11339587355728692
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.009161724	0.11339587355728692
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009160123999999999	0.11337607014499336
MACHADO-JOSEPH DISEASE TYPE 3	0.00915114	0.11326487398496514
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00915114	0.11326487398496514
LARYNGOTRACHEAL ANGIOMA	0.00915114	0.11326487398496514
MACHADO-JOSEPH DISEASE TYPE 1	0.00915114	0.11326487398496514
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00915114	0.11326487398496514
MACHADO-JOSEPH DISEASE TYPE 2	0.00915114	0.11326487398496514
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009059484	0.11213043551172944
CHAR SYNDROME	0.009037264	0.11185541562350285
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009037264	0.11185541562350285
CHROMOSOME 15Q25 DELETION SYNDROME	0.009022084	0.11166753074936785
JOUBERT SYNDROME 2	0.009020134	0.11164339534063511
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.009020134	0.11164339534063511
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.009020134	0.11164339534063511
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.11164339534063511
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009020134	0.11164339534063511
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009020134	0.11164339534063511
OROFACIODIGITAL SYNDROME VI	0.009020134	0.11164339534063511
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009020134	0.11164339534063511
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.11164339534063511
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.009020134	0.11164339534063511
RING CHROMOSOME 12 SYNDROME	0.009020134	0.11164339534063511
OROFACIODIGITAL SYNDROME TYPE 6	0.009020134	0.11164339534063511
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009020134	0.11164339534063511
ADAMS-OLIVER SYNDROME 1; AOS1	0.009020134	0.11164339534063511
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.009020134	0.11164339534063511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009020134	0.11164339534063511
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009020134	0.11164339534063511
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00896098	0.11091123843387742
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00894701	0.1107383298902894
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00894701	0.1107383298902894
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00894701	0.1107383298902894
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00894701	0.1107383298902894
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.008884504	0.10996468483477671
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008884504	0.10996468483477671
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.008884504	0.10996468483477671
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.008833134	0.10932887152882712
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.008833134	0.10932887152882712
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.008802830000000001	0.1089537948999874
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.008781394000000001	0.10868847868378465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.008781394000000001	0.10868847868378465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.008781394000000001	0.10868847868378465
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.008781394000000001	0.10868847868378465
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.10857134150006832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.10857134150006832
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.10857134150006832
BREATH-HOLDING SPELLS	0.00877193	0.10857134150006832
PINEOBLASTOMA	0.00877193	0.10857134150006832
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.10857134150006832
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.10857134150006832
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.10857134150006832
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.10857134150006832
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.10857134150006832
MILROY DISEASE	0.00877193	0.10857134150006832
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.10857134150006832
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.10857134150006832
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.10857134150006832
HUNTINGTON DISEASE	0.00877193	0.10857134150006832
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.10857134150006832
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006832
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.10857134150006832
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.10857134150006832
CAFFEY DISEASE	0.00877193	0.10857134150006832
CRYPTOCOCCOSIS	0.00877193	0.10857134150006832
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.10857134150006832
KEIPERT SYNDROME	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.10857134150006832
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.10857134150006832
SNEDDON SYNDROME	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.10857134150006832
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.10857134150006832
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.10857134150006832
CORTICOBASAL SYNDROME	0.00877193	0.10857134150006832
HISTIDINEMIA	0.00877193	0.10857134150006832
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.10857134150006832
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.10857134150006832
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.10857134150006832
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.10857134150006832
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.10857134150006832
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.10857134150006832
LESCH-NYHAN SYNDROME	0.00877193	0.10857134150006832
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.008652739999999999	0.10709611105552609
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.008652739999999999	0.10709611105552609
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.008652739999999999	0.10709611105552609
CRANIOFACIAL DYSSYNOSTOSIS	0.008652739999999999	0.10709611105552609
DISTAL MONOSOMY 10P	0.008652739999999999	0.10709611105552609
NEONATAL ADRENOLEUKODYSTROPHY	0.008652739999999999	0.10709611105552609
LAMB-SHAFFER SYNDROME	0.008621753999999999	0.10671259322219623
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00861617	0.10664347931329178
9Q21.13 MICRODELETION SYNDROME	0.00861617	0.10664347931329178
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00861617	0.10664347931329178
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00861617	0.10664347931329178
20Q13.33 MICRODELETION SYNDROME	0.00861617	0.10664347931329178
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008502294	0.10523402095182952
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.008502294	0.10523402095182952
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.008502294	0.10523402095182952
JOUBERT SYNDROME 14	0.008502294	0.10523402095182952
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.008502294	0.10523402095182952
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008502294	0.10523402095182952
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.008502294	0.10523402095182952
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.008502294	0.10523402095182952
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008502294	0.10523402095182952
DOORS SYNDROME	0.008502294	0.10523402095182952
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00849171	0.10510302137950771
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00847458	0.10489100109663996
PACHYGYRIA, FRONTOTEMPORAL	0.00847458	0.10489100109663996
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.10489100109663996
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.10489100109663996
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.10489100109663996
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.10489100109663996
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00847458	0.10489100109663996
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.10489100109663996
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	0.10489100109663996
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.10489100109663996
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.10489100109663996
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.10489100109663996
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.10489100109663996
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00847458	0.10489100109663996
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.10489100109663996
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.10489100109663996
TUFTED ANGIOMA	0.00847458	0.10489100109663996
SCLEROSTEOSIS 1; SOST1	0.00847458	0.10489100109663996
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.10489100109663996
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00847458	0.10489100109663996
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.10489100109663996
WIEDEMANN-STEINER SYNDROME; WDSTS	0.008434984	0.10440091615090547
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008434984	0.10440091615090547
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008434984	0.10440091615090547
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00833895	0.10321229059078157
MOEBIUS SYNDROME	0.00828758	0.10257647728483196
CHIME SYNDROME	0.00828758	0.10257647728483196
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.008235840000000001	0.1019360844397895
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.008235840000000001	0.1019360844397895
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00814257	0.1007816692744027
STEVENS-JOHNSON SYNDROME	0.00814257	0.1007816692744027
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.008103054	0.10029257449928289
SOTOS SYNDROME 2	0.0080762	0.09996019897820113
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00795674	0.09848162670783438
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00795674	0.09848162670783438
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00795674	0.09848162670783438
PROTEUS SYNDROME	0.00795674	0.09848162670783438
KABUKI SYNDROME	0.00795674	0.09848162670783438
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.0984348906548216
300270 ADRENOMYODYSTROPHY	0.007952964	0.0984348906548216
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.007952964	0.0984348906548216
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.0984348906548216
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.0984348906548216
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.0984348906548216
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.007914794	0.09796245550029374
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.007914794	0.09796245550029374
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.007914794	0.09796245550029374
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.007914794	0.09796245550029374
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007914794	0.09796245550029374
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00788943	0.09764852190691033
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0078545	0.09721618866227691
GM1 GANGLIOSIDOSIS	0.0078545	0.09721618866227691
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007791934	0.09644180097880323
PRIMARY CONGENITAL HYPOTHYROIDISM	0.007791934	0.09644180097880323
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007791934	0.09644180097880323
NIEMANN-PICK DISEASE TYPE C	0.007791934	0.09644180097880323
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.007791934	0.09644180097880323
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007791934	0.09644180097880323
PERIPHERAL HYPOTHYROIDISM	0.007791934	0.09644180097880323
BAND HETEROTOPIA; BH	0.007791934	0.09644180097880323
SEVERE CANAVAN DISEASE	0.007791934	0.09644180097880323
AUSTRALIA ANTIGEN	0.007587804	0.09391525688412748
17Q12 MICRODELETION SYNDROME	0.007587804	0.09391525688412748
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.09391525688412748
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.09391525688412748
COWDEN SYNDROME	0.007587804	0.09391525688412748
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00740741	0.09168249641082647
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.09168249641082647
FRYNS SYNDROME	0.00740741	0.09168249641082647
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.09168249641082647
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.09168249641082647
BOWEN-CONRADI SYNDROME	0.00740741	0.09168249641082647
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.09168249641082647
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.09168249641082647
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00740741	0.09168249641082647
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.09168249641082647
ADRENOMYODYSTROPHY	0.00740741	0.09168249641082647
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.09168249641082647
CROME SYNDROME	0.00740741	0.09168249641082647
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.09168249641082647
YUNIS-VARON SYNDROME	0.00740741	0.09168249641082647
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.09168249641082647
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.09168249641082647
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.09168249641082647
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.09168249641082647
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.09168249641082647
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.09168249641082647
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.09168249641082647
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.09168249641082647
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.09168249641082647
SECKEL SYNDROME 7; SCKL7	0.00740741	0.09168249641082647
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.09168249641082647
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.09168249641082647
DPM1-CDG	0.00740741	0.09168249641082647
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.09168249641082647
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00736924	0.0912100612562986
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00736924	0.0912100612562986
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00736924	0.0912100612562986
MICROTIA	0.00736924	0.0912100612562986
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00736924	0.0912100612562986
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.007292764	0.09026350765719793
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007256964	0.08982040630712987
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.007256964	0.08982040630712987
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.08982040630712987
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.007256964	0.08982040630712987
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.007256964	0.08982040630712987
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.08982040630712987
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007256964	0.08982040630712987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.007256964	0.08982040630712987
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.007256964	0.08982040630712987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.007256964	0.08982040630712987
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.007256964	0.08982040630712987
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.007256964	0.08982040630712987
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.007256964	0.08982040630712987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.007256964	0.08982040630712987
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	0.08982040630712987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007256964	0.08982040630712987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.007256964	0.08982040630712987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.08982040630712987
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.08982040630712987
CITRULLINEMIA, CLASSIC	0.007256964	0.08982040630712987
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.007256964	0.08982040630712987
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.007256964	0.08982040630712987
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.007256964	0.08982040630712987
AICARDI-GOUTIERES SYNDROME 5	0.007256964	0.08982040630712987
AICARDI-GOUTIÈRES SYNDROME	0.007256964	0.08982040630712987
NARP SYNDROME	0.007256964	0.08982040630712987
JOUBERT SYNDROME 10	0.007256964	0.08982040630712987
SHWACHMAN-DIAMOND SYNDROME	0.007256964	0.08982040630712987
ARGININOSUCCINIC ACIDURIA	0.007256964	0.08982040630712987
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.007256964	0.08982040630712987
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.007256964	0.08982040630712987
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.007256964	0.08982040630712987
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.007256964	0.08982040630712987
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.007255364	0.08980060289483634
8P23.1 MICRODELETION SYNDROME	0.007255364	0.08980060289483634
19P13.13 MICRODELETION SYNDROME	0.007255364	0.08980060289483634
INCONTINENTIA PIGMENTI	0.007255364	0.08980060289483634
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.08968940673480809
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00724638	0.08968940673480809
BRONCHOPULMONARY DYSPLASIA	0.00724638	0.08968940673480809
HEREDITARY HYPEREKPLEXIA	0.00724638	0.08968940673480809
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00724638	0.08968940673480809
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00724638	0.08968940673480809
NEURALGIC AMYOTROPHY	0.00724638	0.08968940673480809
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.08968940673480809
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.08968940673480809
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.007189654	0.08898730150620583
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.007189654	0.08898730150620583
11P15.4 MICRODUPLICATION SYNDROME	0.007189654	0.08898730150620583
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.007189654	0.08898730150620583
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.007189654	0.08898730150620583
3C SYNDROME	0.0071547239999999995	0.0885549682615724
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.007054104	0.08730958117096214
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.007054104	0.08730958117096214
RING CHROMOSOME 13 SYNDROME	0.00704225	0.08716286264013234
NANCE-HORAN SYNDROME	0.00704225	0.08716286264013234
GOLDENHAR SYNDROME	0.00704225	0.08716286264013234
HYPERLEXIA	0.00704225	0.08716286264013234
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013234
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00683087	0.08454658433350148
MEIER-GORLIN SYNDROME 6; MGORS6	0.00674721	0.08351111341320279
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00671141	0.08306801206313473
IMMUNODEFICIENCY 32A	0.00671141	0.08306801206313473
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	0.08306801206313473
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00671141	0.08306801206313473
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00671141	0.08306801206313473
IDIOPATHIC APLASTIC ANEMIA	0.00671141	0.08306801206313473
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313473
UROCANIC ACIDURIA	0.00671141	0.08306801206313473
LETTERER-SIWE DISEASE	0.00671141	0.08306801206313473
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	0.08306801206313473
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.00671141	0.08306801206313473
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.00671141	0.08306801206313473
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	0.08306801206313473
IMMUNODEFICIENCY 9; IMD9	0.00671141	0.08306801206313473
TUFTSIN DEFICIENCY	0.00671141	0.08306801206313473
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	0.08306801206313473
IMMUNODEFICIENCY 55; IMD55	0.00671141	0.08306801206313473
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00671141	0.08306801206313473
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00671141	0.08306801206313473
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00671141	0.08306801206313473
LAZY LEUKOCYTE SYNDROME	0.00671141	0.08306801206313473
BULLOUS PEMPHIGOID	0.00671141	0.08306801206313473
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00671141	0.08306801206313473
IMMUNODEFICIENCY 52; IMD52	0.00671141	0.08306801206313473
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313473
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313473
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00671141	0.08306801206313473
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313473
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313473
224250 DYSMYELINATION WITH JAUNDICE	0.00671141	0.08306801206313473
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	0.08306801206313473
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313473
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00671141	0.08306801206313473
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00671141	0.08306801206313473
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313473
HYPOPHOSPHATASIA	0.00671141	0.08306801206313473
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	0.08306801206313473
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313473
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00671141	0.08306801206313473
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00671141	0.08306801206313473
CYSTIC DISEASE OF LUNG	0.00671141	0.08306801206313473
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313473
WALDENSTRÖM MACROGLOBULINEMIA	0.00671141	0.08306801206313473
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00671141	0.08306801206313473
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	0.08306801206313473
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	0.08306801206313473
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00671141	0.08306801206313473
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313473
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00671141	0.08306801206313473
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	0.08306801206313473
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313473
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313473
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313473
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313473
IMMUNODEFICIENCY 37; IMD37	0.00671141	0.08306801206313473
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313473
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00671141	0.08306801206313473
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00671141	0.08306801206313473
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.00671141	0.08306801206313473
BEHCET SYNDROME	0.00671141	0.08306801206313473
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00671141	0.08306801206313473
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00671141	0.08306801206313473
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	0.08306801206313473
CONGENITAL ATRANSFERRINEMIA	0.00671141	0.08306801206313473
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	0.08306801206313473
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313473
BETA-THALASSEMIA	0.00671141	0.08306801206313473
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	0.08306801206313473
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313473
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313473
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313473
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00671141	0.08306801206313473
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00671141	0.08306801206313473
PSEUDODIASTROPHIC DYSPLASIA	0.00671141	0.08306801206313473
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00670981	0.08304820865084118
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.006707694	0.08302201863808298
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.006707694	0.08302201863808298
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.006707694	0.08302201863808298
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00660917	0.08180257401757726
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00660917	0.08180257401757726
ACROOSTEOLYSIS DOMINANT TYPE	0.00660917	0.08180257401757726
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00660917	0.08180257401757726
LEPRECHAUNISM	0.00660917	0.08180257401757726
ACERULOPLASMINEMIA	0.0063492	0.07858489083385684
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0063492	0.07858489083385684
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.006336334000000001	0.07842564664475138
MALAN OVERGROWTH SYNDROME	0.00617144	0.07638473172804408
RENPENNING SYNDROME 1; RENS1	0.00617144	0.07638473172804408
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.006047434	0.0748498930124983
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006010034	0.0743869882501367
MARDEN-WALKER SYNDROME	0.006010034	0.0743869882501367
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006010034	0.0743869882501367
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.006010034	0.0743869882501367
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00598467	0.07407305465675329
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00598467	0.07407305465675329
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005946814000000001	0.07360450592188804
RETINAL CONE DYSTROPHY 3B	0.005790780000000001	0.07167325240075624
HIDROTIC ECTODERMAL DYSPLASIA	0.005790780000000001	0.07167325240075624
OCULOCUTANEOUS ALBINISM	0.005790780000000001	0.07167325240075624
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.005790780000000001	0.07167325240075624
OCULOCUTANEOUS ALBINISM TYPE 2	0.005790780000000001	0.07167325240075624
X-LINKED RECESSIVE OCULAR ALBINISM	0.005790780000000001	0.07167325240075624
LEBER CONGENITAL AMAUROSIS 16	0.005790780000000001	0.07167325240075624
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005790780000000001	0.07167325240075624
GAPO SYNDROME; GAPOS	0.005790780000000001	0.07167325240075624
XERODERMA PIGMENTOSUM	0.005790780000000001	0.07167325240075624
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.005790780000000001	0.07167325240075624
OCULOCUTANEOUS ALBINISM TYPE 1B	0.005790780000000001	0.07167325240075624
HERMANSKY-PUDLAK SYNDROME	0.005790780000000001	0.07167325240075624
OCULOCUTANEOUS ALBINISM TYPE 4	0.005790780000000001	0.07167325240075624
OCULAR ALBINISM	0.005790780000000001	0.07167325240075624
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00568977	0.07042303822839942
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00568977	0.07042303822839942
GAUCHER DISEASE	0.00568977	0.07042303822839942
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00550188	0.06809749876850316
CHITAYAT SYNDROME	0.00550188	0.06809749876850316
19Q13.11 MICRODELETION SYNDROME	0.00550188	0.06809749876850316
ALAZAMI SYNDROME; ALAZS	0.005471664	0.06772351132733957
DYSTONIA-APHONIA SYNDROME	0.005471664	0.06772351132733957
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005471664	0.06772351132733957
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614155
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.06763459400614155
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.06763459400614155
LEGIUS SYNDROME	0.00546448	0.06763459400614155
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614155
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614155
SPINOCEREBELLAR ATAXIA TYPE 36	0.00546448	0.06763459400614155
CHROMOSOME 9P DELETION SYNDROME	0.005462364	0.06760840399338335
SIALIDOSIS TYPE 2	0.005462364	0.06760840399338335
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.005462364	0.06760840399338335
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.005462364	0.06760840399338335
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.005462364	0.06760840399338335
COFFIN-SIRIS SYNDROME	0.005388004	0.06668804040704088
WOLF-HIRSCHHORN SYNDROME	0.005388004	0.06668804040704088
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.005388004	0.06668804040704088
MENTAL RETARDATION, X-LINKED 101; MRX101	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005287384000000001	0.06544265331643062
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.005287384000000001	0.06544265331643062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.005287384000000001	0.06544265331643062
HADZISELIMOVIC SYNDROME	0.005287384000000001	0.06544265331643062
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.005287384000000001	0.06544265331643062
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.005287384000000001	0.06544265331643062
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005287384000000001	0.06544265331643062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005287384000000001	0.06544265331643062
OPTIC ATROPHY 11; OPA11	0.005287384000000001	0.06544265331643062
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005287384000000001	0.06544265331643062
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005287384000000001	0.06544265331643062
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005287384000000001	0.06544265331643062
PONTINE TEGMENTAL CAP DYSPLASIA	0.005287384000000001	0.06544265331643062
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005287384000000001	0.06544265331643062
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.005287384000000001	0.06544265331643062
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, X-LINKED 99	0.005284894	0.06541183425604878
JAWAD SYNDROME	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005284894	0.06541183425604878
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.005284894	0.06541183425604878
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.005284894	0.06541183425604878
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005284894	0.06541183425604878
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.005284894	0.06541183425604878
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.005284894	0.06541183425604878
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.005284894	0.06541183425604878
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0050910040000000005	0.06301203200005173
L1 SYNDROME	0.004989994	0.06176181782769492
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004989994	0.06176181782769492
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.060971117083344434
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.060971117083344434
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.060971117083344434
GENIOSPASM 1; GSM1	0.00492611	0.060971117083344434
PANIC DISORDER 1	0.00492611	0.060971117083344434
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.060971117083344434
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.060971117083344434
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00491681	0.06085600974938821
GAUCHER DISEASE TYPE 2	0.00484245	0.05993564616304574
GAUCHER DISEASE TYPE 3	0.00484245	0.05993564616304574
JACOBSEN SYNDROME	0.00484245	0.05993564616304574
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00484245	0.05993564616304574
STICKLER SYNDROME	0.00484245	0.05993564616304574
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004802934	0.059446551387925935
BOHRING-OPITZ SYNDROME	0.004802934	0.059446551387925935
ARTERIAL TORTUOSITY SYNDROME	0.004802934	0.059446551387925935
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.004802934	0.059446551387925935
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.004802934	0.059446551387925935
2Q31.1 MICRODELETION SYNDROME	0.004802934	0.059446551387925935
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004802934	0.059446551387925935
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004802934	0.059446551387925935
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.004802934	0.059446551387925935
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.004802934	0.059446551387925935
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.004802934	0.059446551387925935
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004741830000000001	0.05869025907243549
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004741830000000001	0.05869025907243549
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.05865944001205365
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.05865944001205365
MENTAL RETARDATION, X-LINKED 102	0.00473934	0.05865944001205365
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.05865944001205365
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.05865944001205365
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.05865944001205365
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.05865944001205365
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.05865944001205365
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.05865944001205365
YELLOW FEVER	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.0562596377560566
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.0562596377560566
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.0562596377560566
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.0562596377560566
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.0562596377560566
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.0562596377560566
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.0562596377560566
SCRUB TYPHUS	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 4	0.00454545	0.0562596377560566
CONE DYSTROPHY 3	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.0562596377560566
BLAU SYNDROME	0.00454545	0.0562596377560566
OLIGOCONE TRICHROMACY	0.00454545	0.0562596377560566
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00454545	0.0562596377560566
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 10	0.00454545	0.0562596377560566
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.0562596377560566
ALBINISM, OCULAR, TYPE I	0.00454545	0.0562596377560566
CORNEAL FLECK DYSTROPHY	0.00454545	0.0562596377560566
SJÖGREN-LARSSON SYNDROME	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.0562596377560566
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.0562596377560566
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.0562596377560566
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00454545	0.0562596377560566
ERMINE PHENOTYPE	0.00454545	0.0562596377560566
CONE DYSTROPHY 4	0.00454545	0.0562596377560566
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.0562596377560566
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 17	0.00454545	0.0562596377560566
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.0562596377560566
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.0562596377560566
LEUKONYCHIA TOTALIS	0.00454545	0.0562596377560566
MACULAR CORNEAL DYSTROPHY	0.00454545	0.0562596377560566
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.0562596377560566
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00454545	0.0562596377560566
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00454545	0.0562596377560566
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.0562596377560566
AMOEBIC KERATITIS	0.00454545	0.0562596377560566
COGAN SYNDROME	0.00454545	0.0562596377560566
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.0562596377560566
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.0562596377560566
ALACRIMA	0.00454545	0.0562596377560566
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.0562596377560566
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 79	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.0562596377560566
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.0562596377560566
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.0562596377560566
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00454545	0.0562596377560566
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.0562596377560566
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.0562596377560566
ALPORT SYNDROME	0.00454545	0.0562596377560566
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.0562596377560566
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 16	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.0562596377560566
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.0562596377560566
ACHROMATOPSIA 7; ACHM7	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.0562596377560566
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.0562596377560566
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.0562596377560566
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00454545	0.0562596377560566
IRVAN SYNDROME	0.00454545	0.0562596377560566
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.0562596377560566
JALILI SYNDROME	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.0562596377560566
NEOVASCULAR GLAUCOMA	0.00454545	0.0562596377560566
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.0562596377560566
TYROSINEMIA TYPE 2	0.00454545	0.0562596377560566
BRADYOPSIA	0.00454545	0.0562596377560566
CORNEODERMATOOSSEOUS SYNDROME	0.00454545	0.0562596377560566
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.0562596377560566
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.0562596377560566
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.0562596377560566
IDIOPATHIC PANUVEITIS	0.00454545	0.0562596377560566
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00454545	0.0562596377560566
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.0562596377560566
CONE ROD DYSTROPHY	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.0562596377560566
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.0562596377560566
BLUE CONE MONOCHROMATISM	0.00454545	0.0562596377560566
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.0562596377560566
EEC SYNDROME	0.00454545	0.0562596377560566
CORNEODERMATOOSSEOUS SYNDROME	0.00454545	0.0562596377560566
FLOTCH SYNDROME	0.00454545	0.0562596377560566
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.0562596377560566
ALACRIMA, CONGENITAL	0.00454545	0.0562596377560566
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.055009423583699785
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.055009423583699785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.055009423583699785
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00444444	0.055009423583699785
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.055009423583699785
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.055009423583699785
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.055009423583699785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.055009423583699785
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.055009423583699785
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00444444	0.055009423583699785
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.055009423583699785
GLUCAGONOMA	0.00444444	0.055009423583699785
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.055009423583699785
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.055009423583699785
CENTRAL NEUROCYTOMA	0.00444444	0.055009423583699785
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00444444	0.055009423583699785
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.055009423583699785
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.055009423583699785
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.055009423583699785
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00425738	0.052694157143930796
TRISOMY 20P	0.00425738	0.052694157143930796
FOCAL DERMAL HYPOPLASIA; FDH	0.00425738	0.052694157143930796
SHPRINTZEN-GOLDBERG SYNDROME	0.00425738	0.052694157143930796
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00425738	0.052694157143930796
ACROCALLOSAL SYNDROME; ACLS	0.00425738	0.052694157143930796
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00425738	0.052694157143930796
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00425738	0.052694157143930796
SCARF SYNDROME	0.00425738	0.052694157143930796
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00425738	0.052694157143930796
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00425738	0.052694157143930796
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00425738	0.052694157143930796
PALLISTER-KILLIAN SYNDROME	0.00425738	0.052694157143930796
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00425738	0.052694157143930796
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00425738	0.052694157143930796
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00425738	0.052694157143930796
SCARF SYNDROME	0.00425738	0.052694157143930796
FEMORAL-FACIAL SYNDROME	0.00425738	0.052694157143930796
MARDEN-WALKER SYNDROME	0.00425738	0.052694157143930796
FOCAL DERMAL HYPOPLASIA	0.00425738	0.052694157143930796
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004142674	0.05127442576234124
ICF SYNDROME	0.004142674	0.05127442576234124
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.004142674	0.05127442576234124
TAY-SACHS DISEASE	0.004142674	0.05127442576234124
HEREDITARY OROTIC ACIDURIA	0.004142674	0.05127442576234124
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004142674	0.05127442576234124
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.004142674	0.05127442576234124
TETRASOMY 5P	0.004142674	0.05127442576234124
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004142674	0.05127442576234124
FREE SIALIC ACID STORAGE DISEASE	0.004142674	0.05127442576234124
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004142674	0.05127442576234124
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.004142674	0.05127442576234124
DYSKERATOSIS CONGENITA	0.004142674	0.05127442576234124
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004142674	0.05127442576234124
EARLY MYOCLONIC ENCEPHALOPATHY	0.004142674	0.05127442576234124
FARBER DISEASE	0.004142674	0.05127442576234124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004042054000000001	0.05002903867173099
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004042054000000001	0.05002903867173099
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004042054000000001	0.05002903867173099
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004042054000000001	0.05002903867173099
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.05002903867173099
CHROMOSOME 1P35 DELETION SYNDROME	0.004042054000000001	0.05002903867173099
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004042054000000001	0.05002903867173099
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004042054000000001	0.05002903867173099
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004042054000000001	0.05002903867173099
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004042054000000001	0.05002903867173099
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004042054000000001	0.05002903867173099
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004042054000000001	0.05002903867173099
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004042054000000001	0.05002903867173099
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004042054000000001	0.05002903867173099
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004042054000000001	0.05002903867173099
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004042054000000001	0.05002903867173099
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.05002903867173099
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004042054000000001	0.05002903867173099
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.05002903867173099
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004042054000000001	0.05002903867173099
MENTAL RETARDATION, X-LINKED 103	0.004042054000000001	0.05002903867173099
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004042054000000001	0.05002903867173099
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.004042054000000001	0.05002903867173099
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004042054000000001	0.05002903867173099
PEHO-LIKE SYNDROME; PEHOL	0.004042054000000001	0.05002903867173099
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004042054000000001	0.05002903867173099
FOIX-CHAVANY-MARIE SYNDROME	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004042054000000001	0.05002903867173099
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004042054000000001	0.05002903867173099
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.05002903867173099
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004042054000000001	0.05002903867173099
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004042054000000001	0.05002903867173099
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004042054000000001	0.05002903867173099
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004042054000000001	0.05002903867173099
LISSENCEPHALY 8; LIS8	0.004042054000000001	0.05002903867173099
IMMUNODEFICIENCY 49; IMD49	0.004042054000000001	0.05002903867173099
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.004042054000000001	0.05002903867173099
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004042054000000001	0.05002903867173099
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004042054000000001	0.05002903867173099
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.05002903867173099
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004042054000000001	0.05002903867173099
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004042054000000001	0.05002903867173099
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.004042054000000001	0.05002903867173099
JOUBERT SYNDROME 24	0.004042054000000001	0.05002903867173099
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004042054000000001	0.05002903867173099
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004042054000000001	0.05002903867173099
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004042054000000001	0.05002903867173099
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004042054000000001	0.05002903867173099
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004042054000000001	0.05002903867173099
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.05002903867173099
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0036956439999999997	0.045741476138851815
6Q TERMINAL DELETION SYNDROME	0.0036956439999999997	0.045741476138851815
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0036956439999999997	0.045741476138851815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0036956439999999997	0.045741476138851815
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0036956439999999997	0.045741476138851815
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.0036956439999999997	0.045741476138851815
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0036956439999999997	0.045741476138851815
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0036956439999999997	0.045741476138851815
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0036956439999999997	0.045741476138851815
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0036956439999999997	0.045741476138851815
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0036956439999999997	0.045741476138851815
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0036956439999999997	0.045741476138851815
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036956439999999997	0.045741476138851815
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0036956439999999997	0.045741476138851815
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0036956439999999997	0.045741476138851815
1Q44 MICRODELETION SYNDROME	0.0036956439999999997	0.045741476138851815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0036956439999999997	0.045741476138851815
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0036956439999999997	0.045741476138851815
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0036956439999999997	0.045741476138851815
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0036956439999999997	0.045741476138851815
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0036956439999999997	0.045741476138851815
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.044522031518346106
VAN DEN BOSCH SYNDROME	0.00359712	0.044522031518346106
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00359712	0.044522031518346106
PRIMARY ERYTHROMELALGIA	0.00359712	0.044522031518346106
DERMATOMYOSITIS	0.00359712	0.044522031518346106
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00359712	0.044522031518346106
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00359712	0.044522031518346106
ODONTOCHONDRODYSPLASIA; ODCD	0.00359712	0.044522031518346106
PAROXYSMAL COLD HEMOGLOBINURIA	0.00359712	0.044522031518346106
IMMUNODEFICIENCY 32B; IMD32B	0.00359712	0.044522031518346106
RETICULAR DYSGENESIS	0.00359712	0.044522031518346106
SANDHOFF DISEASE	0.00359712	0.044522031518346106
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00359712	0.044522031518346106
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00359712	0.044522031518346106
ATAXIA-PANCYTOPENIA SYNDROME	0.00359712	0.044522031518346106
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00359712	0.044522031518346106
BETA-MANNOSIDOSIS	0.00359712	0.044522031518346106
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00359712	0.044522031518346106
IMMUNODEFICIENCY 43	0.00359712	0.044522031518346106
LARYNX ATRESIA	0.00359712	0.044522031518346106
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.00359712	0.044522031518346106
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00359712	0.044522031518346106
OPSISMODYSPLASIA	0.00359712	0.044522031518346106
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00359712	0.044522031518346106
CYSTIC FIBROSIS	0.00359712	0.044522031518346106
ALOPECIA ANTIBODY DEFICIENCY	0.00359712	0.044522031518346106
PULMONARY ARTERIAL HYPERTENSION	0.00359712	0.044522031518346106
LIPOID PROTEINOSIS	0.00359712	0.044522031518346106
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00359712	0.044522031518346106
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00359712	0.044522031518346106
GRANULOMATOSIS WITH POLYANGIITIS	0.00359712	0.044522031518346106
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00359712	0.044522031518346106
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00359712	0.044522031518346106
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00359712	0.044522031518346106
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00359712	0.044522031518346106
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00359712	0.044522031518346106
THORACIC DYSOSTOSIS, ISOLATED	0.00359712	0.044522031518346106
LAMELLAR ICHTHYOSIS	0.00359712	0.044522031518346106
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.00359712	0.044522031518346106
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00359712	0.044522031518346106
LYMPHANGIOLEIOMYOMATOSIS	0.00359712	0.044522031518346106
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.00359712	0.044522031518346106
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.00359712	0.044522031518346106
ZLOTOGORA-OGUR SYNDROME	0.00359712	0.044522031518346106
IMMUNODEFICIENCY 22; IMD22	0.00359712	0.044522031518346106
HENNEKAM SYNDROME	0.00359712	0.044522031518346106
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00359712	0.044522031518346106
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.00359712	0.044522031518346106
GAMMA-HEAVY CHAIN DISEASE	0.00359712	0.044522031518346106
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00359712	0.044522031518346106
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.00359712	0.044522031518346106
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00359712	0.044522031518346106
MARTSOLF SYNDROME	0.00359712	0.044522031518346106
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00359712	0.044522031518346106
DIASTROPHIC DWARFISM	0.00359712	0.044522031518346106
RETINITIS PIGMENTOSA 6	0.00359712	0.044522031518346106
IMMUNODEFICIENCY 57; IMD57	0.00359712	0.044522031518346106
CHRONIC GRANULOMATOUS DISEASE	0.00359712	0.044522031518346106
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00359712	0.044522031518346106
MALT LYMPHOMA	0.00359712	0.044522031518346106
NIEMANN-PICK DISEASE, TYPE B	0.00359712	0.044522031518346106
BLOOM SYNDROME	0.00359712	0.044522031518346106
PARTIAL ATRIOVENTRICULAR CANAL	0.00359712	0.044522031518346106
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00359712	0.044522031518346106
GLYCOGEN STORAGE DISEASE II	0.00359712	0.044522031518346106
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00359712	0.044522031518346106
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00359712	0.044522031518346106
MELNICK-NEEDLES SYNDROME	0.00359712	0.044522031518346106
JUNG SYNDROME	0.00359712	0.044522031518346106
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.00359712	0.044522031518346106
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00359712	0.044522031518346106
SANJAD-SAKATI SYNDROME	0.00359712	0.044522031518346106
CYCLIC NEUTROPENIA	0.00359712	0.044522031518346106
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00359712	0.044522031518346106
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00359712	0.044522031518346106
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00359712	0.044522031518346106
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.00359712	0.044522031518346106
YELLOW NAIL SYNDROME	0.00359712	0.044522031518346106
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00359712	0.044522031518346106
SPINAL MUSCULAR ATROPHY, TYPE II	0.00359712	0.044522031518346106
WISKOTT-ALDRICH SYNDROME	0.00359712	0.044522031518346106
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.00359712	0.044522031518346106
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.00359712	0.044522031518346106
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00359712	0.044522031518346106
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00359712	0.044522031518346106
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00359712	0.044522031518346106
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00359712	0.044522031518346106
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00359712	0.044522031518346106
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00359712	0.044522031518346106
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00359712	0.044522031518346106
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.00359712	0.044522031518346106
OPSISMODYSPLASIA; OPSMD	0.00359712	0.044522031518346106
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.044522031518346106
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00359712	0.044522031518346106
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00359712	0.044522031518346106
SPASTIC PARAPLEGIA TYPE 2	0.00359712	0.044522031518346106
HYPEREKPLEXIA 4; HKPX4	0.003557604	0.044032936743226295
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.003557604	0.044032936743226295
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.003557604	0.044032936743226295
KAGAMI-OGATA SYNDROME	0.003557604	0.044032936743226295
17P13.3 MICRODUPLICATION SYNDROME	0.003557604	0.044032936743226295
PETERS PLUS SYNDROME	0.003557604	0.044032936743226295
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.003557604	0.044032936743226295
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.003557604	0.044032936743226295
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003557604	0.044032936743226295
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003557604	0.044032936743226295
CATEL-MANZKE SYNDROME; CATMANS	0.003557604	0.044032936743226295
RUVALCABA SYNDROME	0.003557604	0.044032936743226295
DIAPHANOSPONDYLODYSOSTOSIS	0.003557604	0.044032936743226295
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003557604	0.044032936743226295
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.003557604	0.044032936743226295
KAGAMI-OGATA SYNDROME	0.003557604	0.044032936743226295
PERLMAN SYNDROME	0.003557604	0.044032936743226295
LATERAL MENINGOCELE SYNDROME	0.003557604	0.044032936743226295
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003557604	0.044032936743226295
AYMÉ-GRIPP SYNDROME	0.003557604	0.044032936743226295
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003557604	0.044032936743226295
PSEUDOAMINOPTERIN SYNDROME	0.003557604	0.044032936743226295
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003557604	0.044032936743226295
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003557604	0.044032936743226295
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.003557604	0.044032936743226295
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.003557604	0.044032936743226295
OROFACIODIGITAL SYNDROME XVI; OFD16	0.003557604	0.044032936743226295
WEAVER SYNDROME	0.003557604	0.044032936743226295
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.04327664442773584
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.04327664442773584
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0034965000000000005	0.04327664442773584
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0034965000000000005	0.04327664442773584
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0034965000000000005	0.04327664442773584
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0034965000000000005	0.04327664442773584
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.04327664442773584
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.04327664442773584
14Q12 MICRODELETION SYNDROME	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.04327664442773584
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.04327664442773584
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0034965000000000005	0.04327664442773584
OLIVER SYNDROME	0.0034965000000000005	0.04327664442773584
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.04327664442773584
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0034965000000000005	0.04327664442773584
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0034965000000000005	0.04327664442773584
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0034965000000000005	0.04327664442773584
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.04327664442773584
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.04327664442773584
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.04327664442773584
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.04327664442773584
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.04327664442773584
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00315009	0.038989081894856684
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00315009	0.038989081894856684
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00315009	0.038989081894856684
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00315009	0.038989081894856684
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00315009	0.038989081894856684
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00301205	0.037280542499231156
HUNTER-MACDONALD SYNDROME	0.00301205	0.037280542499231156
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00301205	0.037280542499231156
SIMOSA CRANIOFACIAL SYNDROME	0.00301205	0.037280542499231156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00301205	0.037280542499231156
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00301205	0.037280542499231156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00301205	0.037280542499231156
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, TYPE I	0.00301205	0.037280542499231156
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00301205	0.037280542499231156
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00301205	0.037280542499231156
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00301205	0.037280542499231156
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00301205	0.037280542499231156
HYPEREKPLEXIA 1; HKPX1	0.00301205	0.037280542499231156
VACTERL WITH HYDROCEPHALUS	0.00301205	0.037280542499231156
OSTEOGENESIS IMPERFECTA	0.00301205	0.037280542499231156
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00301205	0.037280542499231156
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00301205	0.037280542499231156
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00301205	0.037280542499231156
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00301205	0.037280542499231156
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.00301205	0.037280542499231156
WIDOW'S PEAK SYNDROME	0.00301205	0.037280542499231156
OMPHALOCELE, AUTOSOMAL	0.00301205	0.037280542499231156
LAMBERT SYNDROME	0.00301205	0.037280542499231156
HERNIA, DOUBLE INGUINAL	0.00301205	0.037280542499231156
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00301205	0.037280542499231156
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00301205	0.037280542499231156
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00301205	0.037280542499231156
MUCOLIPIDOSIS TYPE III	0.00301205	0.037280542499231156
268650 RUDIGER SYNDROME	0.00301205	0.037280542499231156
EXSTROPHY OF BLADDER	0.00301205	0.037280542499231156
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.037280542499231156
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.00301205	0.037280542499231156
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00301205	0.037280542499231156
ACROCALLOSAL SYNDROME	0.00301205	0.037280542499231156
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00301205	0.037280542499231156
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00301205	0.037280542499231156
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00301205	0.037280542499231156
ADAMS-OLIVER SYNDROME 5; AOS5	0.00301205	0.037280542499231156
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00301205	0.037280542499231156
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00301205	0.037280542499231156
X-LINKED EHLERS-DANLOS SYNDROME	0.00301205	0.037280542499231156
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00301205	0.037280542499231156
SHORT SYNDROME	0.00301205	0.037280542499231156
BRITTLE CORNEA SYNDROME 2; BCS2	0.00301205	0.037280542499231156
LATERAL MENINGOCELE SYNDROME	0.00301205	0.037280542499231156
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00301205	0.037280542499231156
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00301205	0.037280542499231156
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00301205	0.037280542499231156
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00301205	0.037280542499231156
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00301205	0.037280542499231156
RHINY	0.00301205	0.037280542499231156
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00301205	0.037280542499231156
DISTAL MONOSOMY 3P	0.00301205	0.037280542499231156
FRANK-TER HAAR SYNDROME	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00301205	0.037280542499231156
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00301205	0.037280542499231156
BRUCK SYNDROME 2	0.00301205	0.037280542499231156
OSTEOGLOSPHONIC DYSPLASIA	0.00301205	0.037280542499231156
RUVALCABA SYNDROME	0.00301205	0.037280542499231156
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00301205	0.037280542499231156
ARTERIAL TORTUOSITY SYNDROME	0.00301205	0.037280542499231156
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00301205	0.037280542499231156
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00301205	0.037280542499231156
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00301205	0.037280542499231156
POLYDACTYLY-MYOPIA SYNDROME	0.00301205	0.037280542499231156
NEURAMINIDASE DEFICIENCY	0.00301205	0.037280542499231156
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00301205	0.037280542499231156
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00301205	0.037280542499231156
AUTOSOMAL DOMINANT CUTIS LAXA	0.00301205	0.037280542499231156
DIPHALLIA	0.00301205	0.037280542499231156
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00301205	0.037280542499231156
OSTEOGENESIS IMPERFECTA, TYPE X	0.00301205	0.037280542499231156
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00301205	0.037280542499231156
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00301205	0.037280542499231156
MICROSPHEROPHAKIA WITH HERNIA	0.00301205	0.037280542499231156
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.00301205	0.037280542499231156
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00301205	0.037280542499231156
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00301205	0.037280542499231156
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.00301205	0.037280542499231156
ULNAR-MAMMARY SYNDROME; UMS	0.00301205	0.037280542499231156
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00301205	0.037280542499231156
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.037280542499231156
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00301205	0.037280542499231156
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00301205	0.037280542499231156
FACIOCARDIORENAL SYNDROME	0.00301205	0.037280542499231156
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00301205	0.037280542499231156
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00301205	0.037280542499231156
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00301205	0.037280542499231156
ISOLATED HEMIHYPERPLASIA	0.00301205	0.037280542499231156
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00301205	0.037280542499231156
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00301205	0.037280542499231156
LAMBERT SYNDROME	0.00301205	0.037280542499231156
COFFIN-LOWRY SYNDROME; CLS	0.00301205	0.037280542499231156
ACHONDROGENESIS	0.00301205	0.037280542499231156
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00301205	0.037280542499231156
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00301205	0.037280542499231156
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00301205	0.037280542499231156
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00301205	0.037280542499231156
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002450314	0.030327861494152182
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002450314	0.030327861494152182
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.030327861494152182
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002450314	0.030327861494152182
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002450314	0.030327861494152182
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.030327861494152182
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.002450314	0.030327861494152182
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.030327861494152182
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002450314	0.030327861494152182
EPILEPSY, PYRIDOXINE-DEPENDENT	0.002450314	0.030327861494152182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002450314	0.030327861494152182
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.030327861494152182
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	0.030327861494152182
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	0.030327861494152182
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002450314	0.030327861494152182
AL KAISSI SYNDROME; ALKAS	0.002450314	0.030327861494152182
EPIDERMAL NEVUS SYNDROME	0.002450314	0.030327861494152182
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.030327861494152182
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.030327861494152182
SHASHI-PENA SYNDROME; SHAPNS	0.002450314	0.030327861494152182
NOONAN SYNDROME 6; NS6	0.002450314	0.030327861494152182
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	0.030327861494152182
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002450314	0.030327861494152182
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.002450314	0.030327861494152182
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.030327861494152182
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.002450314	0.030327861494152182
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.030327861494152182
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.030327861494152182
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.030327861494152182
LIG4 SYNDROME	0.002450314	0.030327861494152182
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002450314	0.030327861494152182
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.002450314	0.030327861494152182
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002450314	0.030327861494152182
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.002450314	0.030327861494152182
SAY-BARBER-MILLER SYNDROME	0.002450314	0.030327861494152182
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.030327861494152182
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	0.030327861494152182
FORSYTHE-WAKELING SYNDROME; FWS	0.002450314	0.030327861494152182
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002450314	0.030327861494152182
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.002450314	0.030327861494152182
8P23.1 DUPLICATION SYNDROME	0.002450314	0.030327861494152182
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002450314	0.030327861494152182
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002450314	0.030327861494152182
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	0.030327861494152182
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002450314	0.030327861494152182
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002450314	0.030327861494152182
GALACTOSE EPIMERASE DEFICIENCY	0.002450314	0.030327861494152182
17Q11.2 MICRODUPLICATION SYNDROME	0.002450314	0.030327861494152182
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.030327861494152182
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002450314	0.030327861494152182
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.030327861494152182
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002450314	0.030327861494152182
OKAMOTO SYNDROME	0.002450314	0.030327861494152182
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.002450314	0.030327861494152182
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.030327861494152182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002450314	0.030327861494152182
12Q14 MICRODELETION SYNDROME	0.002450314	0.030327861494152182
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	0.030327861494152182
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.002450314	0.030327861494152182
GENITOPATELLAR SYNDROME	0.002450314	0.030327861494152182
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.030327861494152182
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.002450314	0.030327861494152182
PELIZAEUS-MERZBACHER DISEASE	0.002450314	0.030327861494152182
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.002450314	0.030327861494152182
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.002450314	0.030327861494152182
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.030327861494152182
7P22.1 MICRODUPLICATION SYNDROME	0.002450314	0.030327861494152182
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.023575467250157047
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.023575467250157047
CRANIOSYNOSTOSIS 7	0.00190476	0.023575467250157047
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.023575467250157047
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.023575467250157047
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00190476	0.023575467250157047
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.023575467250157047
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.023575467250157047
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.023575467250157047
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.023575467250157047
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.023575467250157047
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00190476	0.023575467250157047
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.023575467250157047
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.023575467250157047
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.023575467250157047
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.023575467250157047
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.023575467250157047
FG SYNDROME 2; FGS2	0.00190476	0.023575467250157047
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.023575467250157047
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.023575467250157047
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00190476	0.023575467250157047
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.023575467250157047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.023575467250157047
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.023575467250157047
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.023575467250157047
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	0.023575467250157047
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.023575467250157047
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	0.023575467250157047
EPISODIC ATAXIA TYPE 1	0.00190476	0.023575467250157047
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.023575467250157047
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.023575467250157047
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.023575467250157047
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.023575467250157047
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.023575467250157047
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.023575467250157047
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00190476	0.023575467250157047
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.023575467250157047
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.023575467250157047
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.023575467250157047
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.023575467250157047
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00190476	0.023575467250157047
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.023575467250157047
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	0.023575467250157047
20P13 MICRODELETION SYNDROME	0.00190476	0.023575467250157047
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00190476	0.023575467250157047
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00190476	0.023575467250157047
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	0.023575467250157047
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.023575467250157047
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.023575467250157047
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.023575467250157047
NAGER SYNDROME	0.00190476	0.023575467250157047
MASA SYNDROME	0.00190476	0.023575467250157047
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.023575467250157047
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00190476	0.023575467250157047
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.023575467250157047
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.023575467250157047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.023575467250157047
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.023575467250157047
DYSTONIA 16; DYT16	0.00190476	0.023575467250157047
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	0.023575467250157047
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.023575467250157047
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.023575467250157047
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.023575467250157047
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.023575467250157047
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.023575467250157047
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.023575467250157047
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.023575467250157047
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.023575467250157047
PARTINGTON SYNDROME	0.00190476	0.023575467250157047
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.023575467250157047
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.023575467250157047
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.023575467250157047
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.023575467250157047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.023575467250157047
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.023575467250157047
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.023575467250157047
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.023575467250157047
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	0.023575467250157047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.023575467250157047
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.023575467250157047
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.023575467250157047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.023575467250157047
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.023575467250157047
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.023575467250157047
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001790884	0.02216600888869477
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001790884	0.02216600888869477
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001790884	0.02216600888869477
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001790884	0.02216600888869477
CRANIOSYNOSTOSIS 6; CRS6	0.001790884	0.02216600888869477
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001790884	0.02216600888869477
MONOSOMY 9P	0.001790884	0.02216600888869477
TRISOMY 17P	0.001790884	0.02216600888869477
RAHMAN SYNDROME	0.001790884	0.02216600888869477
SENIOR-LOKEN SYNDROME 9	0.001790884	0.02216600888869477
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.02216600888869477
XQ21 MICRODELETION SYNDROME	0.001790884	0.02216600888869477
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.02216600888869477
CARDIOFACIOCUTANEOUS SYNDROME	0.001790884	0.02216600888869477
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001790884	0.02216600888869477
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001790884	0.02216600888869477
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.02216600888869477
TOLUENE EMBRYOPATHY	0.001790884	0.02216600888869477
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.02216600888869477
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.02216600888869477
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	0.02216600888869477
JOUBERT SYNDROME 21	0.001790884	0.02216600888869477
FETAL TRIMETHADIONE SYNDROME	0.001790884	0.02216600888869477
POTOCKI-SHAFFER SYNDROME	0.001790884	0.02216600888869477
PHACE SYNDROME	0.001790884	0.02216600888869477
SCHINDLER DISEASE, TYPE I	0.001790884	0.02216600888869477
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.02216600888869477
SCHIZENCEPHALY	0.001790884	0.02216600888869477
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.02216600888869477
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.02216600888869477
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	0.02216600888869477
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	0.02216600888869477
TREACHER-COLLINS SYNDROME	0.001790884	0.02216600888869477
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	0.02216600888869477
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	0.02216600888869477
KBG SYNDROME	0.001790884	0.02216600888869477
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001790884	0.02216600888869477
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001790884	0.02216600888869477
DUANE RETRACTION SYNDROME	0.001790884	0.02216600888869477
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001790884	0.02216600888869477
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001790884	0.02216600888869477
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	0.02216600888869477
ZTTK SYNDROME; ZTTKS	0.001790884	0.02216600888869477
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.02216600888869477
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001790884	0.02216600888869477
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.02216600888869477
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.02216600888869477
MEIER-GORLIN SYNDROME 7	0.001790884	0.02216600888869477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.02216600888869477
MATERNAL PHENYLKETONURIA	0.001790884	0.02216600888869477
JOUBERT SYNDROME WITH RENAL DEFECT	0.001790884	0.02216600888869477
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	0.02216600888869477
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	0.02216600888869477
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001790884	0.02216600888869477
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.02216600888869477
CODAS SYNDROME	0.001790884	0.02216600888869477
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001790884	0.02216600888869477
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	0.02216600888869477
MARINESCO-SJÖGREN SYNDROME	0.001790884	0.02216600888869477
GERMAN SYNDROME	0.001790884	0.02216600888869477
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	0.02216600888869477
OPTIC PATHWAY GLIOMA	0.001790884	0.02216600888869477
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	0.02216600888869477
ROTHMUND-THOMSON SYNDROME	0.001790884	0.02216600888869477
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	0.02216600888869477
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	0.02216600888869477
JOUBERT SYNDROME	0.001790884	0.02216600888869477
MONOSOMY 18Q	0.001790884	0.02216600888869477
3MC SYNDROME 2	0.001790884	0.02216600888869477
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02216600888869477
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	0.02216600888869477
COHEN SYNDROME	0.001790884	0.02216600888869477
X SMALL RINGS	0.001790884	0.02216600888869477
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	0.02216600888869477
OCULOECTODERMAL SYNDROME; OES	0.001790884	0.02216600888869477
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.02216600888869477
FRONTOOCULAR SYNDROME	0.001790884	0.02216600888869477
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001790884	0.02216600888869477
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.02216600888869477
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.02216600888869477
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	0.02216600888869477
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001790884	0.02216600888869477
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001790884	0.02216600888869477
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.02216600888869477
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.02216600888869477
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.001790884	0.02216600888869477
SSR4-CDG	0.001790884	0.02216600888869477
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001790884	0.02216600888869477
ISOLATED PLAGIOCEPHALY	0.001790884	0.02216600888869477
BOHRING-OPITZ SYNDROME	0.001790884	0.02216600888869477
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001790884	0.02216600888869477
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.02216600888869477
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001790884	0.02216600888869477
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	0.02216600888869477
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.02216600888869477
MONOSOMY 9Q22.3	0.001790884	0.02216600888869477
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001790884	0.02216600888869477
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.02216600888869477
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.015413614644699635
MULTIMINICORE MYOPATHY	0.00124533	0.015413614644699635
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00124533	0.015413614644699635
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.015413614644699635
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00124533	0.015413614644699635
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.015413614644699635
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	0.015413614644699635
BASAL CELL NEVUS SYNDROME	0.00124533	0.015413614644699635
ROBINOW-SORAUF SYNDROME	0.00124533	0.015413614644699635
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	0.015413614644699635
NOONAN SYNDROME	0.00124533	0.015413614644699635
IVIC SYNDROME	0.00124533	0.015413614644699635
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.015413614644699635
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.015413614644699635
MOSAIC TRISOMY 8	0.00124533	0.015413614644699635
NANOPHTHALMOS	0.00124533	0.015413614644699635
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.015413614644699635
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.015413614644699635
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00124533	0.015413614644699635
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.015413614644699635
WOOLLY HAIR	0.00124533	0.015413614644699635
MORNING GLORY DISC ANOMALY	0.00124533	0.015413614644699635
MEIER-GORLIN SYNDROME 1; MGORS1	0.00124533	0.015413614644699635
BRANCHIOOCULOFACIAL SYNDROME	0.00124533	0.015413614644699635
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.015413614644699635
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.015413614644699635
COOPER-JABS SYNDROME	0.00124533	0.015413614644699635
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.015413614644699635
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.015413614644699635
HYPERTELORISM, TEEBI TYPE	0.00124533	0.015413614644699635
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.015413614644699635
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.015413614644699635
15Q OVERGROWTH SYNDROME	0.00124533	0.015413614644699635
JACKSON-WEISS SYNDROME	0.00124533	0.015413614644699635
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.015413614644699635
KNOBLOCH SYNDROME	0.00124533	0.015413614644699635
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.015413614644699635
MCDONOUGH SYNDROME	0.00124533	0.015413614644699635
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.015413614644699635
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.015413614644699635
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.015413614644699635
NON-DISTAL MONOSOMY 10Q	0.00124533	0.015413614644699635
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.015413614644699635
IVIC SYNDROME	0.00124533	0.015413614644699635
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.015413614644699635
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.015413614644699635
ODONTOCHONDRODYSPLASIA	0.00124533	0.015413614644699635
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.015413614644699635
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699635
LAURENCE-MOON SYNDROME	0.00124533	0.015413614644699635
COCKAYNE SYNDROME A; CSA	0.00124533	0.015413614644699635
TRISOMY 4P	0.00124533	0.015413614644699635
LEIGH SYNDROME	0.00124533	0.015413614644699635
CARTILAGE-HAIR HYPOPLASIA	0.00124533	0.015413614644699635
MARSHALL SYNDROME	0.00124533	0.015413614644699635
ABDUCENS PALSY	0.00124533	0.015413614644699635
APERT SYNDROME	0.00124533	0.015413614644699635
MCDONOUGH SYNDROME	0.00124533	0.015413614644699635
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	0.015413614644699635
HALLERMANN-STREIFF SYNDROME	0.00124533	0.015413614644699635
X-LINKED RETINAL DYSPLASIA	0.00124533	0.015413614644699635
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.015413614644699635
TETRASOMY 12P	0.00124533	0.015413614644699635
15Q26 OVERGROWTH SYNDROME	0.00124533	0.015413614644699635
CROUZON DISEASE	0.00124533	0.015413614644699635
GASTROCUTANEOUS SYNDROME	0.00124533	0.015413614644699635
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.015413614644699635
LAMBOTTE SYNDROME	0.00124533	0.015413614644699635
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.015413614644699635
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00124533	0.015413614644699635
EEM SYNDROME	0.00124533	0.015413614644699635
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699635
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.015413614644699635
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	0.015413614644699635
COCKAYNE SYNDROME	0.00124533	0.015413614644699635
WAARDENBURG SYNDROME TYPE 1	0.00124533	0.015413614644699635
FETAL IODINE SYNDROME	0.00124533	0.015413614644699635
JOHANSON-BLIZZARD SYNDROME; JBS	0.00124533	0.015413614644699635
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00124533	0.015413614644699635
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.015413614644699635
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00124533	0.015413614644699635
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.015413614644699635
MUSCLE-EYE-BRAIN DISEASE	0.00124533	0.015413614644699635
PROXIMAL SYMPHALANGISM	0.00124533	0.015413614644699635
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.015413614644699635
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.015413614644699635
RETINOBLASTOMA	0.00124533	0.015413614644699635
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.015413614644699635
SUMMITT SYNDROME	0.00124533	0.015413614644699635
NOONAN SYNDROME 7; NS7	0.00124533	0.015413614644699635
DYSEQUILIBRIUM SYNDROME	0.00124533	0.015413614644699635
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.015413614644699635
GLUTATHIONURIA	0.00124533	0.015413614644699635
TOWNES-BROCKS SYNDROME	0.00124533	0.015413614644699635
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.015413614644699635
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.015413614644699635
RENPENNING SYNDROME	0.00124533	0.015413614644699635
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.015413614644699635
CONGENITAL HYDROCEPHALUS	0.00124533	0.015413614644699635
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.015413614644699635
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00124533	0.015413614644699635
DIAMOND-BLACKFAN ANEMIA 1	0.00124533	0.015413614644699635
SECKEL SYNDROME 5; SCKL5	0.00124533	0.015413614644699635
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00124533	0.015413614644699635
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699635
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00124533	0.015413614644699635
ALAGILLE SYNDROME	0.00124533	0.015413614644699635
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.015413614644699635
DESMOSTEROLOSIS	0.00124533	0.015413614644699635
MOWAT-WILSON SYNDROME	0.00124533	0.015413614644699635
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.015413614644699635
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.015413614644699635
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	0.015413614644699635
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00124533	0.015413614644699635
PETERS ANOMALY	0.00124533	0.015413614644699635
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.015413614644699635
RENAL COLOBOMA SYNDROME	0.00124533	0.015413614644699635
HEMIFACIAL MICROSOMIA	0.00124533	0.015413614644699635
MASA SYNDROME	0.00124533	0.015413614644699635
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.015413614644699635
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.015413614644699635
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.015413614644699635
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.015413614644699635
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	0.015413614644699635
8Q21.11 MICRODELETION SYNDROME	0.00124533	0.015413614644699635
PELVISCAPULAR DYSPLASIA	0.00124533	0.015413614644699635
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.015413614644699635
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00124533	0.015413614644699635
ADAMS-OLIVER SYNDROME	0.00124533	0.015413614644699635
BRANCHIO-OCULO-FACIAL SYNDROME	0.00124533	0.015413614644699635
FANCONI ANEMIA	0.00124533	0.015413614644699635
ANTLEY-BIXLER SYNDROME	0.00124533	0.015413614644699635
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.015413614644699635
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.015413614644699635
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.015413614644699635
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00124533	0.015413614644699635
SECKEL SYNDROME 1; SCKL1	0.00124533	0.015413614644699635
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00124533	0.015413614644699635
COATS DISEASE	0.00124533	0.015413614644699635
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.015413614644699635
BRANCHIOSKELETOGENITAL SYNDROME	0.00124533	0.015413614644699635
ALAGILLE SYNDROME 1; ALGS1	0.00124533	0.015413614644699635
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.015413614644699635
BENCZE SYNDROME	0.00124533	0.015413614644699635
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.015413614644699635
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.015413614644699635
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.015413614644699635
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699635
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.015413614644699635
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.015413614644699635
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00124533	0.015413614644699635
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.015413614644699635
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00124533	0.015413614644699635
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00124533	0.015413614644699635
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00124533	0.015413614644699635
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.015413614644699635
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.015413614644699635
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.015413614644699635
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.015413614644699635
PETERS ANOMALY	0.00124533	0.015413614644699635
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.015413614644699635
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.015413614644699635
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.015413614644699635
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.015413614644699635
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.015413614644699635
STIFF SKIN SYNDROME	0.00124533	0.015413614644699635
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.015413614644699635
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.015413614644699635
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00124533	0.015413614644699635
CHANARIN-DORFMAN SYNDROME	0.00124533	0.015413614644699635
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.015413614644699635
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.015413614644699635
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.015413614644699635
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.015413614644699635
CROSSED POLYSYNDACTYLY	0.00124533	0.015413614644699635
SENGERS SYNDROME	0.00124533	0.015413614644699635
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.015413614644699635
COSTELLO SYNDROME	0.00124533	0.015413614644699635
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.015413614644699635
CONGENITAL RUBELLA SYNDROME	0.00124533	0.015413614644699635
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.015413614644699635
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.015413614644699635
LERI PLEONOSTEOSIS	0.00124533	0.015413614644699635
PRIMARY CUTIS VERTICIS GYRATA	0.00124533	0.015413614644699635
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.015413614644699635
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.015413614644699635
INCONTINENTIA PIGMENTI; IP	0.00124533	0.015413614644699635
FRONTORHINY	0.00124533	0.015413614644699635
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	0.015413614644699635
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.015413614644699635
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.015413614644699635
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.015413614644699635
OTOMANDIBULAR SYNDROME	0.00124533	0.015413614644699635
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00124533	0.015413614644699635
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.015413614644699635
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.015413614644699635
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.015413614644699635
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00124533	0.015413614644699635
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.015413614644699635
LINEAR VERRUCOUS NEVUS SYNDROME	0.00124533	0.015413614644699635
ELLIS VAN CREVELD SYNDROME	0.00124533	0.015413614644699635
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	0.015413614644699635
OPTIC ATROPHY 1; OPA1	0.00124533	0.015413614644699635
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00124533	0.015413614644699635
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.015413614644699635
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.015413614644699635
GRISCELLI SYNDROME TYPE 1	0.000545554	0.006752394243995137
ALG6-CDG	0.000545554	0.006752394243995137
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.006752394243995137
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.006752394243995137
RIGID SPINE SYNDROME	0.000545554	0.006752394243995137
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.006752394243995137
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.006752394243995137
WALKER-WARBURG SYNDROME	0.000545554	0.006752394243995137
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.006752394243995137
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.006752394243995137
LIG4 SYNDROME	0.000545554	0.006752394243995137
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.006752394243995137
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995137
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995137
ALG3-CDG	0.000545554	0.006752394243995137
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995137
ZEBRA BODY MYOPATHY	0.000545554	0.006752394243995137
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.006752394243995137
MONOSOMY 13Q34	0.000545554	0.006752394243995137
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.006752394243995137
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.006752394243995137
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.006752394243995137
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.006752394243995137
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995137
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995137
RECOMBINANT 8 SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.006752394243995137
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.006752394243995137
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995137
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.006752394243995137
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.006752394243995137
WOLMAN DISEASE	0.000545554	0.006752394243995137
THYROID HYPOPLASIA	0.000545554	0.006752394243995137
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.006752394243995137
PALLISTER-HALL SYNDROME	0.000545554	0.006752394243995137
COACH SYNDROME	0.000545554	0.006752394243995137
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.006752394243995137
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.006752394243995137
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.006752394243995137
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.006752394243995137
LEBER CONGENITAL AMAUROSIS	0.000545554	0.006752394243995137
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.006752394243995137
HYDROXYKYNURENINURIA	0.000545554	0.006752394243995137
KBG SYNDROME	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.006752394243995137
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.006752394243995137
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.006752394243995137
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.006752394243995137
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.006752394243995137
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.006752394243995137
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.006752394243995137
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.006752394243995137
PFEIFFER SYNDROME TYPE 2	0.000545554	0.006752394243995137
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.006752394243995137
DISTAL MONOSOMY 19P13.3	0.000545554	0.006752394243995137
MOSAIC TRISOMY 9	0.000545554	0.006752394243995137
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.006752394243995137
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.006752394243995137
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.006752394243995137
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.006752394243995137
DPAGT1-CDG	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.006752394243995137
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.006752394243995137
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.006752394243995137
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.006752394243995137
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.006752394243995137
CONGENITAL TOXOPLASMOSIS	0.000545554	0.006752394243995137
BRESEK SYNDROME	0.000545554	0.006752394243995137
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.006752394243995137
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.006752394243995137
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.006752394243995137
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995137
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.006752394243995137
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.006752394243995137
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.006752394243995137
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.006752394243995137
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.006752394243995137
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.006752394243995137
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.006752394243995137
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.006752394243995137
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.006752394243995137
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.006752394243995137
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.006752394243995137
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.006752394243995137
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.006752394243995137
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.006752394243995137
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.006752394243995137
CANAVAN DISEASE	0.000545554	0.006752394243995137
STEEL SYNDROME; STLS	0.000545554	0.006752394243995137
CINCA SYNDROME	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995137
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.006752394243995137
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.006752394243995137
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995137
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.006752394243995137
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.006752394243995137
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.006752394243995137
CULLER-JONES SYNDROME; CJS	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.006752394243995137
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.006752394243995137
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.006752394243995137
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.006752394243995137
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.006752394243995137
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.006752394243995137
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.006752394243995137
NOONAN SYNDROME 11; NS11	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.006752394243995137
SECKEL SYNDROME 8; SCKL8	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.006752394243995137
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.006752394243995137
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.006752394243995137
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995137
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.006752394243995137
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.006752394243995137
EAST SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 11	0.000545554	0.006752394243995137
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.006752394243995137
COLE-CARPENTER SYNDROME	0.000545554	0.006752394243995137
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.006752394243995137
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995137
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.006752394243995137
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.006752394243995137
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.006752394243995137
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.006752394243995137
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.006752394243995137
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.006752394243995137
LISSENCEPHALY 4	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.006752394243995137
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.006752394243995137
DONNAI-BARROW SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY	0.000545554	0.006752394243995137
ZECHI-CEIDE SYNDROME	0.000545554	0.006752394243995137
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995137
HYDRANENCEPHALY	0.000545554	0.006752394243995137
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.006752394243995137
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.006752394243995137
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.006752394243995137
JOUBERT SYNDROME 15	0.000545554	0.006752394243995137
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.006752394243995137
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.006752394243995137
2P21 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.006752394243995137
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.006752394243995137
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.006752394243995137
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.006752394243995137
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.006752394243995137
TRISOMY 12P	0.000545554	0.006752394243995137
MOSAIC TRISOMY 14	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.006752394243995137
DISTAL TRISOMY 18Q	0.000545554	0.006752394243995137
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.006752394243995137
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.006752394243995137
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.006752394243995137
COFFIN-SIRIS SYNDROME 3; CSS3	0.000545554	0.006752394243995137
TRISOMY 8Q	0.000545554	0.006752394243995137
TEMTAMY SYNDROME	0.000545554	0.006752394243995137
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.006752394243995137
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.006752394243995137
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.006752394243995137
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 2	0.000545554	0.006752394243995137
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.006752394243995137
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.006752394243995137
JOUBERT SYNDROME 27	0.000545554	0.006752394243995137
JOUBERT SYNDROME 28	0.000545554	0.006752394243995137
ALAZAMI-YUAN SYNDROME	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.006752394243995137
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.006752394243995137
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.006752394243995137
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.006752394243995137
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.006752394243995137
CHOPS SYNDROME; CHOPS	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.006752394243995137
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.006752394243995137
MECKEL SYNDROME 13; MKS13	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.006752394243995137
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.006752394243995137
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.006752394243995137
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.006752394243995137
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.006752394243995137
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.006752394243995137
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.006752394243995137
JOUBERT SYNDROME 25	0.000545554	0.006752394243995137
RING CHROMOSOME 14 SYNDROME	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.006752394243995137
AU-KLINE SYNDROME; AUKS	0.000545554	0.006752394243995137
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.006752394243995137
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.006752394243995137
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.006752394243995137
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.006752394243995137
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.006752394243995137
NOONAN SYNDROME 9; NS9	0.000545554	0.006752394243995137
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.006752394243995137
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.006752394243995137
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.006752394243995137
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.006752394243995137
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.006752394243995137
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.006752394243995137
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.006752394243995137
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.006752394243995137
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.006752394243995137
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.006752394243995137
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.006752394243995137
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.006752394243995137
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.006752394243995137
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.006752394243995137
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.006752394243995137
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.006752394243995137
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.006752394243995137
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.006752394243995137
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.006752394243995137
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.006752394243995137
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.006752394243995137
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.006752394243995137
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.006752394243995137
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.006752394243995137
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.006752394243995137
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.006752394243995137
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.006752394243995137
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.006752394243995137
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.006752394243995137
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.006752394243995137
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.006752394243995137
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.006752394243995137
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.006752394243995137
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.006752394243995137
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.006752394243995137
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.006752394243995137
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.006752394243995137
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.006752394243995137
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.006752394243995137
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995137
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.006752394243995137
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.006752394243995137
TARP SYNDROME; TARPS	0.000545554	0.006752394243995137
WAISMAN SYNDROME; WSMN	0.000545554	0.006752394243995137
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.006752394243995137
DISTAL MONOSOMY 1Q	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.006752394243995137
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.006752394243995137
STT3A-CDG	0.000545554	0.006752394243995137
STT3B-CDG	0.000545554	0.006752394243995137
GRISCELLI SYNDROME	0.000545554	0.006752394243995137
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.006752394243995137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.006752394243995137
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.006752394243995137
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.006752394243995137
MEND SYNDROME; MEND	0.000545554	0.006752394243995137
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.006752394243995137
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.006752394243995137
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.006752394243995137
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.006752394243995137
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.006752394243995137
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.006752394243995137
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.006752394243995137
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.006752394243995137
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.006752394243995137
SRD5A3-CDG	0.000545554	0.006752394243995137
CURRY-JONES SYNDROME	0.000545554	0.006752394243995137
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.006752394243995137
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.006752394243995137
ISOVALERIC ACIDEMIA	0.000545554	0.006752394243995137
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995137
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.006752394243995137
DISTAL TRISOMY 17Q	0.000545554	0.006752394243995137
TRISOMY 18	0.000545554	0.006752394243995137
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.006752394243995137
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.006752394243995137
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.006752394243995137
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.006752394243995137
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.006752394243995137
CODAS SYNDROME	0.000545554	0.006752394243995137
YUNIS-VARON SYNDROME	0.000545554	0.006752394243995137
LOWRY-MACLEAN SYNDROME	0.000545554	0.006752394243995137
FUCOSIDOSIS	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.006752394243995137
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.006752394243995137
GALACTOSEMIA	0.000545554	0.006752394243995137
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.006752394243995137
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.006752394243995137
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.006752394243995137
PELLAGRA-LIKE SYNDROME	0.000545554	0.006752394243995137
PEHO SYNDROME; PEHO	0.000545554	0.006752394243995137
RAINE SYNDROME	0.000545554	0.006752394243995137
OROTIC ACIDURIA	0.000545554	0.006752394243995137
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.006752394243995137
LISSENCEPHALY 2; LIS2	0.000545554	0.006752394243995137
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.006752394243995137
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.006752394243995137
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.006752394243995137
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.006752394243995137
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.006752394243995137
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.006752394243995137
MAPLE SYRUP URINE DISEASE	0.000545554	0.006752394243995137
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.006752394243995137
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.006752394243995137
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.006752394243995137
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.006752394243995137
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.006752394243995137
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995137
MACDERMOT-WINTER SYNDROME	0.000545554	0.006752394243995137
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995137
ATELOSTEOGENESIS TYPE III	0.000545554	0.006752394243995137
KETOADIPICACIDURIA	0.000545554	0.006752394243995137
PETERS-PLUS SYNDROME; PTRPLS	0.000545554	0.006752394243995137
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.006752394243995137
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.006752394243995137
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.006752394243995137
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.006752394243995137
COG2-CDG	0.000545554	0.006752394243995137
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.006752394243995137
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.006752394243995137
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.006752394243995137
WAARDENBURG-SHAH SYNDROME	0.000545554	0.006752394243995137
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.006752394243995137
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.006752394243995137
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.006752394243995137
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.006752394243995137
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995137
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.006752394243995137
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.006752394243995137
LATHOSTEROLOSIS	0.000545554	0.006752394243995137
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.006752394243995137
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.006752394243995137
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.006752394243995137
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.006752394243995137
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.006752394243995137
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.006752394243995137
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.006752394243995137
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.006752394243995137
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.006752394243995137
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.006752394243995137
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.006752394243995137
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.006752394243995137
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.006752394243995137
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.006752394243995137
JOUBERT SYNDROME 7	0.000545554	0.006752394243995137
NOONAN SYNDROME 5; NS5	0.000545554	0.006752394243995137
N SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.006752394243995137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.006752394243995137
20P12.3 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 7	0.000545554	0.006752394243995137
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.006752394243995137
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.006752394243995137
JOUBERT SYNDROME 6	0.000545554	0.006752394243995137
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.006752394243995137
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.006752394243995137
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.006752394243995137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.006752394243995137
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.006752394243995137
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.006752394243995137
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.006752394243995137
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.006752394243995137
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995137
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.006752394243995137
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.006752394243995137
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.006752394243995137
JOUBERT SYNDROME 8	0.000545554	0.006752394243995137
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.006752394243995137
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.006752394243995137
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.006752394243995137
MICROVILLUS INCLUSION DISEASE	0.000545554	0.006752394243995137
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.006752394243995137
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.006752394243995137
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.006752394243995137
TRISOMY 9P	0.000545554	0.006752394243995137
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.006752394243995137
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.006752394243995137
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.006752394243995137
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.006752394243995137
RFT1-CDG	0.000545554	0.006752394243995137
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.006752394243995137
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.006752394243995137
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.006752394243995137
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.006752394243995137
MICRO SYNDROME	0.000545554	0.006752394243995137
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.006752394243995137
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995137
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.006752394243995137
6Q25 MICRODELETION SYNDROME	0.000545554	0.006752394243995137
8P11.2 DELETION SYNDROME	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.006752394243995137
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.006752394243995137
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.006752394243995137
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.006752394243995137
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.006752394243995137
CDAGS SYNDROME	0.000545554	0.006752394243995137
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.006752394243995137
MEVALONIC ACIDURIA	0.000545554	0.006752394243995137
CONGENITAL VARICELLA SYNDROME	0.000545554	0.006752394243995137
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.006752394243995137
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.006752394243995137
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.006752394243995137
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.006752394243995137
LISSENCEPHALY 1; LIS1	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.006752394243995137
FUMARASE DEFICIENCY; FMRD	0.000545554	0.006752394243995137
PHACE ASSOCIATION	0.000545554	0.006752394243995137
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.006752394243995137
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.006752394243995137
OPITZ G/BBB SYNDROME	0.000545554	0.006752394243995137
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.006752394243995137
NOONAN SYNDROME 2; NS2	0.000545554	0.006752394243995137
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.006752394243995137
OXOGLUTARIC ACIDURIA	0.000545554	0.006752394243995137
ROBERTS SYNDROME	0.000545554	0.006752394243995137
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.006752394243995137
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.006752394243995137
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.006752394243995137
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.006752394243995137
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
SENIOR-LOKEN SYNDROME	0.000545554	0.006752394243995137
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.006752394243995137
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.006752394243995137
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.006752394243995137
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.006752394243995137
TARP SYNDROME	0.000545554	0.006752394243995137
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.006752394243995137
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995137
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.006752394243995137
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.006752394243995137
NOONAN SYNDROME 3; NS3	0.000545554	0.006752394243995137
FRIAS SYNDROME	0.000545554	0.006752394243995137
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.006752394243995137
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.006752394243995137
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.006752394243995137
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.006752394243995137
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.006752394243995137
OTOFACIOCERVICAL SYNDROME	0.000545554	0.006752394243995137
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.006752394243995137
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995137
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.006752394243995137
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.006752394243995137
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.006752394243995137
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.006752394243995137
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.006752394243995137
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.006752394243995137
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.006752394243995137
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.006752394243995137
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995137
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.006752394243995137
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995137
